JPH06293765A - Synthetic intermediate for 1beta-substituted carbapenem antibiotic substance - Google Patents

Synthetic intermediate for 1beta-substituted carbapenem antibiotic substance

Info

Publication number
JPH06293765A
JPH06293765A JP6015043A JP1504394A JPH06293765A JP H06293765 A JPH06293765 A JP H06293765A JP 6015043 A JP6015043 A JP 6015043A JP 1504394 A JP1504394 A JP 1504394A JP H06293765 A JPH06293765 A JP H06293765A
Authority
JP
Japan
Prior art keywords
group
carbon atoms
formula
linear
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP6015043A
Other languages
Japanese (ja)
Inventor
Akira Yoshida
明 吉田
Kozo Oda
晃造 小田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sankyo Co Ltd
Original Assignee
Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co Ltd filed Critical Sankyo Co Ltd
Priority to JP6015043A priority Critical patent/JPH06293765A/en
Publication of JPH06293765A publication Critical patent/JPH06293765A/en
Pending legal-status Critical Current

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

PURPOSE:To obtain the subject compound useful as a practical synthetic intermediate for a carbapenem derivative having excellent antibacterial activity. CONSTITUTION:A compound of formula I [R<1> is H or OH-protecting group; R<2> is 1-6C alkyl, 1-6C alkoxy, halogen, etc.; R<3> is CYNR<5>R<6> (Y is O or sulfur atom; R<5> and R<6> are 1-6C alkyl, phenyl, etc.), H, etc.; R<4> is H or carboxyl- protecting group; (k) is 0-2], e.g. (1R,5S,6S)-2-(2-diethylcarbamoyphenylthio)-1- methyl-6[(R)-1-trimethylsilyoxyethyl]-1-carbapen-2-em-3-carboxylic acid 4- nitrobenzyl ester. The compound of formula I can be produced by reacting a compound of formula II (R<1n> is OH-protecting group) with an acid chloride of formula III and reacting the resultant N-oxyl derivative of formula IV with a phosphorous acid triester or phosphonous acid diester.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明化合物(I)は、すぐれた
抗菌剤である1β−置換カルバペネム誘導体の合成の有
用な中間体である。
BACKGROUND OF THE INVENTION The compound (I) of the present invention is a useful intermediate in the synthesis of 1β-substituted carbapenem derivatives which are excellent antibacterial agents.

【0002】[0002]

【従来の技術】強力な抗菌活性を有するカルバペネム抗
生物質の1β位に置換基を導入すると化学的に安定にな
るのみならず、生体内に存在するジヒドロペプチターゼ
I(DHP-I) に対しても安定になることが見出された。1
β位に置換基をもつカルバペネム抗生物質は天然に得ら
れていないので合成によってそれらをつくる必要があ
り、その合成法が大変注目され、種々の合成法が検討さ
れている。
2. Description of the Related Art Carbapenem antibiotics having strong antibacterial activity not only become chemically stable when a substituent is introduced at the 1β-position, but also against dihydropeptidase I (DHP-I) present in the body. Was also found to be stable. 1
Since carbapenem antibiotics having a substituent at the β-position have not been obtained naturally, it is necessary to prepare them by synthesis, and the synthetic method has received a great deal of attention, and various synthetic methods have been studied.

【0003】1β−メチルカルバペネム誘導体を合成す
る方法の1つとしてB.G.Christensen 等の1β−置換−
2−ケトカルバペナムを中間体とする方法(Heterocycle
s, 21, 29(1984))、または老田等の亜リン酸トリエステ
ルを用いる分子内ウィティッヒ法(特開昭61−508
1)がある。しかしながら前者の方法では1β−置換−
2−ケトカルバペナムが不安定なために、それを用時調
整する必要がある。また、後者の老田等の法に於いては
高温下でウィティッヒ反応を行なうために、目的とする
カルバペネムの2位の置換基によっては分解反応が優先
し閉環反応が進行しにくい場合がある。これらの難点を
克服する方法として以下の反応式に示す杉村らのすぐれ
た方法(特開平1−25780)があるが次の点が問題
となっている。
As one of the methods for synthesizing 1β-methylcarbapenem derivatives, 1β-substitution by BG Christensen et al.
The method of using 2-ketocarbapenamu as an intermediate (Heterocycle
s, 21, 29 (1984)), or the intramolecular Wittig method using phosphite triesters of Ota et al. (JP-A-61-508).
There is 1). However, in the former method, 1β-substitution-
Due to the instability of 2-keto carbapenum, it needs to be adjusted before use. Further, in the latter method of Oita et al., Since the Wittig reaction is carried out at a high temperature, depending on the desired 2-position substituent of the carbapenem, the decomposition reaction may be prioritized and the ring closure reaction may be difficult to proceed. As a method for overcoming these difficulties, there is an excellent method by Sugimura et al. Shown in the following reaction formula (Japanese Patent Laid-Open No. 1-25780), but the following points are problems.

【0004】[0004]

【化4】 [Chemical 4]

【0005】即ちメルカプタンと4−クロロフェニルス
ルフィニル基との付加脱離反応(A→B)の収率(22
%)が低いことである。
That is, the yield (22) of the addition elimination reaction (A → B) between the mercaptan and the 4-chlorophenylsulfinyl group (22)
%) Is low.

【0006】[0006]

【発明の解決しようとしている課題】発明者らは、本発
明の化合物の一つであるスルフィド体(Ia;k=0)
を酸化して得られるスルフィニル体(Ib;k=1)お
よびスルホニル体(Ic;k=2)が金属塩存在下好収
率でメルカプタンと付加脱離反応し、化合物Bなどが得
られることを見出し本発明を完成した。
DISCLOSURE OF THE INVENTION The inventors of the present invention have found that one of the compounds of the present invention is a sulfide (Ia; k = 0).
That the sulfinyl compound (Ib; k = 1) and the sulfonyl compound (Ic; k = 2) obtained by oxidization of the compound undergo an addition-elimination reaction with mercaptan in the presence of a metal salt in a good yield to obtain a compound B or the like. Heading The present invention has been completed.

【0007】[0007]

【課題を解決するための手段】本発明は一般式The present invention has the general formula

【0008】[0008]

【化5】 [Chemical 5]

【0009】を有する化合物である。Is a compound having

【0010】上記式中、R1 は水素原子または水酸基の
保護基を示し、R2 は炭素数1乃至6個の直鎖若しくは
分枝鎖のアルキル基、炭素数1乃至6個の直鎖若しくは
分枝鎖のアルコキシ基、ハロゲン原子、フェニル基又は
フェノキシ基を示し、R3 はCYNR56 基(式中、
Yは酸素又は硫黄原子を示し、R5 及びR6はそれぞれ
独立に炭素数1乃至6個の直鎖若しくは分枝鎖のアルキ
ル基又はフェニル基を示すか、R5 とR6 が一緒になっ
て式−(CH2)m (X)L(CH2)n−基(式中、m及びnは同一
又は異って0乃至5(但し、m+nは2以上である。)
を示し、Lは0または1、Xは酸素原子、R3'は水素原
子、炭素数1乃至6個の直鎖若しくは分枝鎖のアルキル
基、炭素数1乃至6個の直鎖若しくは分枝鎖のアルコキ
シ基、水酸基、ハロゲン原子、シアノ基、ニトロ基を示
し、R4 は水素原子またはカルボキシル基の保護基を示
し、kは0,1,または2を示す。
In the above formula, R 1 represents a hydrogen atom or a hydroxyl-protecting group, R 2 represents a straight chain or branched chain alkyl group having 1 to 6 carbon atoms, a straight chain having 1 to 6 carbon atoms or Represents a branched alkoxy group, a halogen atom, a phenyl group or a phenoxy group, and R 3 represents a CYNR 5 R 6 group (in the formula,
Y represents an oxygen or sulfur atom, R 5 and R 6 each independently represent a linear or branched alkyl group having 1 to 6 carbon atoms or a phenyl group, or R 5 and R 6 are combined. Te formula - (CH 2) m (X ) L (CH 2) n - group (wherein, m and n are 0 to 5 I same or different (provided that, m + n is 2 or more).
L is 0 or 1, X is an oxygen atom, R 3 ′ is a hydrogen atom, a straight-chain or branched-chain alkyl group having 1 to 6 carbon atoms, a straight-chain or branched chain having 1 to 6 carbon atoms. A chain alkoxy group, a hydroxyl group, a halogen atom, a cyano group, or a nitro group, R 4 represents a hydrogen atom or a carboxyl group-protecting group, and k represents 0, 1, or 2.

【0011】前記一般式において、R1 の水酸基の保護
基は、カルバペネム誘導体合成に常用される水酸基の保
護基であり、好適にはt−ブチルジメチルシリル、t−
ブチルジフェニルシリル、トリメチルシリル、トリエチ
ルシリル基のようなトリ置換シリル基、ベンジルオキシ
カルボニル、p−ニトロベンジルオキシカルボニル基の
ようなアラルキルオキシカルボニル基、アセチル、クロ
ロアセチル、メトキシアセチルのような置換していても
よいアセチル基である。
In the above general formula, the hydroxyl-protecting group for R 1 is a hydroxyl-protecting group commonly used in the synthesis of carbapenem derivatives, and is preferably t-butyldimethylsilyl or t-butyldimethylsilyl.
Trisubstituted silyl groups such as butyldiphenylsilyl, trimethylsilyl, triethylsilyl groups, aralkyloxycarbonyl groups such as benzyloxycarbonyl, p-nitrobenzyloxycarbonyl group, acetyl, chloroacetyl, substituted with methoxyacetyl A good acetyl group.

【0012】R2 のハロゲン原子は、フッ素、塩素及び
臭素であり、好適にはフッ素及び塩素である。
The halogen atom for R 2 is fluorine, chlorine and bromine, preferably fluorine and chlorine.

【0013】R3'のハロゲン原子はフッ素、塩素及び臭
素であり、好適には塩素、臭素である。
Halogen atoms [0013] R 3 'is fluorine, chlorine and bromine, preferably chlorine, bromine.

【0014】R4 のカルボキシル基の保護基としては、
カルバペネム誘導体合成に常用されるカルボキシル基の
保護基であり好適にはメチル、エチル、t−ブチルなど
の低級アルキル基、ベンジル、ジフェニルメチル、4−
ニトロベンジル、2−ニトロベンジルなどのアラルキル
基、アリル、2−クロルアリル、2−メチルアリルなど
のアルケニル基、2,2,2 −トリクロルエチル、2,2,2 −
トリブロムエチルなどのハロゲン化アルキル基または2
−(トリメチルシリル)エチル基があげられる。
As the protective group for the carboxyl group of R 4 ,
A protecting group for a carboxyl group commonly used in the synthesis of carbapenem derivatives, preferably a lower alkyl group such as methyl, ethyl, t-butyl, benzyl, diphenylmethyl, 4-
Aralkyl groups such as nitrobenzyl and 2-nitrobenzyl, alkenyl groups such as allyl, 2-chloroallyl and 2-methylallyl, 2,2,2-trichloroethyl, 2,2,2-
Halogenated alkyl groups such as tribromoethyl or 2
An example is a-(trimethylsilyl) ethyl group.

【0015】R2 、R5 、R6 及びR3'の炭素数1乃至
6個の直鎖若しくは分枝鎖のアルキル基としては、メチ
ル、エチル、プロピル、i−ブチル、ペンチル、ヘキシ
ル等があげられ、好適には、メチル、エチル、プロピル
である。
Examples of the linear or branched alkyl group having 1 to 6 carbon atoms represented by R 2 , R 5 , R 6 and R 3 ′ include methyl, ethyl, propyl, i-butyl, pentyl and hexyl. And preferred are methyl, ethyl and propyl.

【0016】R2 ,R3'の炭素数1乃至6個の直鎖若し
くは分枝鎖のアルコキシ基のアルキル部分としては、前
記アルキル基と同様のものがあげられ、好適には、メト
キシ、エトキシ基である。
Examples of the alkyl moiety of the straight-chain or branched-chain alkoxy group having 1 to 6 carbon atoms represented by R 2 and R 3 ′ include those similar to the above-mentioned alkyl groups, and preferably methoxy and ethoxy. It is a base.

【0017】本発明の一般式(I)を有する化合物の具
体例としては、例えば表1,2に記載される化合物をあ
げることができるが、本発明はこれに限定されるもので
はない。
Specific examples of the compound having the general formula (I) of the present invention include the compounds shown in Tables 1 and 2, but the present invention is not limited thereto.

【0018】なお表1については式(I−1)、表2に
ついては式(I−2)を用いる。
The formula (I-1) is used for Table 1 and the formula (I-2) is used for Table 2.

【0019】[0019]

【化6】 [Chemical 6]

【0020】[0020]

【表1】 [Table 1]

【0021】[0021]

【化7】 [Chemical 7]

【0022】[0022]

【表2】 表中、TBSはt−ブチルジメチルシリル基、TMSは
トリメチルシリル基、Phはフェニル基、PNBは4−
ニトロベンジル基、PNZは4−ニトロベンジルオキシ
カルボニル基、A11はアリル基、m−Meはm位にメ
チル基を有することを示す。
[Table 2] In the table, TBS is t-butyldimethylsilyl group, TMS is trimethylsilyl group, Ph is phenyl group, and PNB is 4-.
A nitrobenzyl group, PNZ is a 4-nitrobenzyloxycarbonyl group, A11 is an allyl group, and m-Me is a methyl group at the m-position.

【0023】上記表中、好適な化合物としては、1−
1,1−2,1−3,1−4,1−5,1−6,1−
7,1−8,1−9,1−28,1−29,1−30,
1−31,1−32,1−33,1−34,1−35,
1−36,1−46,1−47,1−48,1−49,
1−50,1−51,1−52,1−53,1−54,
1−64,1−65,1−66,1−67,1−68,
1−69,1−79,1−80,1−81,1−82,
1−83,1−84,2−3,2−4,2−5,2−
7,2−10,2−11,2−12,2−14,2−1
7,2−18,2−19,2−21,2−24,2−2
6,2−28,2−31,2−33,2−35,2−3
8,2−40,2−42,2−45,2−47,2−4
9,2−52,2−54,2−56,2−59,2−6
1及び2−63であり、さらに好適には1−4,1−
5,1−6,1−31,1−32,1−33,1−4
9,1−50,1−51,2−5,2−12,2−1
9,2−26,2−33,2−40,2−47,2−5
4及び2−61であり、最も好適には1−31,1−3
2,1−33,1−49,1−50,1−51,2−2
6,2−33,2−40,2−47,2−54,2−6
1である。
In the above table, preferred compounds include 1-
1,1-2,1-3,1-4,1-5,1-6,1-
7, 1-8, 1-9, 1-28, 1-29, 1-30,
1-31, 1-32, 1-33, 1-34, 1-35,
1-36, 1-46, 1-47, 1-48, 1-49,
1-50, 1-51, 1-52, 1-53, 1-54,
1-64, 1-65, 1-66, 1-67, 1-68,
1-69, 1-79, 1-80, 1-81, 1-82,
1-83, 1-84, 2-3, 2-4, 2-5, 2-
7, 2-10, 2-11, 12-12, 2-14, 2-1
7, 2-18, 2-19, 2-21, 24, 2-2
6,2-28, 2-31, 2-33, 2-35, 2-3
8, 2-40, 2-42, 2-45, 2-47, 2-4
9, 2-52, 2-54, 2-56, 2-59, 2-6
1 and 2-63, and more preferably 1-4, 1-
5, 1-6, 1-31, 1-32, 1-33, 1-4
9, 1-50, 1-51, 2-5, 2-12, 2-1
9,2-26,2-33,2-40,2-47,2-5
4 and 2-61, most preferably 1-31, 1-3
2,1-33,1-49,1-50,1-51,2-2
6, 2-33, 2-40, 2-47, 2-54, 2-6
It is 1.

【0024】本発明に係る化合物(I)は以下の方法に
よって合成することができる。
The compound (I) according to the present invention can be synthesized by the following method.

【0025】A法Method A

【0026】[0026]

【化8】 [Chemical 8]

【0027】上記式中、R1 ,R3 ,R4 及びkは前
述と同意義を示し、R1aはR1 の水酸基の保護基と同意
義を示す。
In the above formula, R 1 , R 3 , R 4 and k have the same meanings as described above, and R 1a has the same meaning as the hydroxyl-protecting group for R 1 .

【0028】R8 は低級アルキル基又は低級アルコキシ
基を示す。R8 の低級アルキル基は例えばメチル,エチ
ル,プロピル,イソプロピル,ブチル,イソブチルがあ
げられる。
R 8 represents a lower alkyl group or a lower alkoxy group. Examples of the lower alkyl group for R 8 include methyl, ethyl, propyl, isopropyl, butyl and isobutyl.

【0029】R8 の低級アルコキシ基は例えばメトキ
シ,エトキシ,プロポキシ,イソプロポキシ,ブトキ
シ,イソブトキシまたはt−ブトキシがあげられる。
The lower alkoxy group for R 8 is, for example, methoxy, ethoxy, propoxy, isopropoxy, butoxy, isobutoxy or t-butoxy.

【0030】R9 は低級アルコキシ基またはアリールオ
キシ基を示す。R9 の低級アルコキシ基はR8 の低級ア
ルコキシ基と同意義を示す。
R 9 represents a lower alkoxy group or an aryloxy group. The lower alkoxy group for R 9 has the same meaning as the lower alkoxy group for R 8 .

【0031】R9 のアリールオキシ基は、例えばフェノ
キシ,4−メチルフェノキシ,4−メトキシフェノキシ
があげられる。
Examples of the aryloxy group of R 9 include phenoxy, 4-methylphenoxy and 4-methoxyphenoxy.

【0032】A法の化合物(II)(特願平4−1740
99号公報)のR1 =TBS,R2 =CH3 ,R3 =2
−CONEt2 ,R3'=Hである化合物(II)はZ
(O)−1−t−ブチルジメチルシリルオキシ−1−
(ジエチルカルバモイルフェニルチオ)−1−プロペン
と(3R,4R)−3−[(R)−1−(t−ブチルジ
メチルシリルオキシ)エチル]−4−アセトキシアゼチ
ジノンとの反応より得られ、この化合物はカラムクロマ
トグラフィ−による精製をすることなく再結晶による精
製法のみで収率77%で得られる。従ってこの化合物は
1β−メチルカルバペネム誘導体の工業的製法の有用な
中間体である。
Compound (II) of Method A (Japanese Patent Application No. 4-1740)
No. 99 publication) R 1 = TBS, R 2 = CH 3 , R 3 = 2
-CONEt 2, R 3 '= a H compound (II) Z
(O) -1-t-butyldimethylsilyloxy-1-
Obtained from the reaction of (diethylcarbamoylphenylthio) -1-propene with (3R, 4R) -3-[(R) -1- (t-butyldimethylsilyloxy) ethyl] -4-acetoxyazetidinone, The compound can be obtained in a yield of 77% only by a purification method by recrystallization without purification by column chromatography. Therefore, this compound is a useful intermediate in the industrial production of 1β-methylcarbapenem derivatives.

【0033】A法は化合物(II)と酸塩化物(III )と
を反応させて得られるN−オキリル誘導体(IV)をさら
に亜リン酸トリエステル又は亜ホスホン酸ジエステルと
反応させて化合物(Ia)を合成する方法で、公知の方
法(Tetrahedron Letters 252793(1984)又は特願平4−
180779)によって達成される。
In the method A, the N-oxylyl derivative (IV) obtained by reacting the compound (II) with the acid chloride (III) is further reacted with a phosphorous acid triester or a phosphonous acid diester to give the compound (Ia). ) Is a known method (Tetrahedron Letters 25 2793 (1984) or Japanese Patent Application No.
180779).

【0034】第1工程 一般式(II)を有する化合物と2〜5モル当量の酸塩化
物(III )を塩基存在下反応させると化合物(IV)が得
られる。
Step 1 The compound (IV) is obtained by reacting the compound having the general formula (II) with 2 to 5 molar equivalents of the acid chloride (III) in the presence of a base.

【0035】使用される塩基としては、反応に関与しな
いものであれば特に限定はないが、たとえば第三級アミ
ンがあげられ、第三級アミンとしてはジイソプロピルエ
チルアミン,ジイソプロピルメチルアミン,トリエチル
アミン,1−エチルピペリジン,1−メチルモルホリ
ン,1−エチルピロリジン,1,4−ジアザビシクロ
〔2,2,2〕オクタン,1,5−ジアザビシクロ
〔5,4,0〕ウンデセン−5または1,5−ジアザビ
シクロ〔4,3,0〕ノネン−5のような環状もしくは
鎖状のアミンがあげられる。
The base used is not particularly limited as long as it does not participate in the reaction, and examples thereof include tertiary amines, and examples of the tertiary amine include diisopropylethylamine, diisopropylmethylamine, triethylamine, 1- Ethylpiperidine, 1-methylmorpholine, 1-ethylpyrrolidine, 1,4-diazabicyclo [2,2,2] octane, 1,5-diazabicyclo [5,4,0] undecene-5 or 1,5-diazabicyclo [4] , 3,0] Nonene-5, such as cyclic or chain amines.

【0036】使用される溶媒としては本反応に関与しな
いものであれば特に限定はないが、メチレンクロライ
ド、クロロホルム、ジクロロエタンのようなハロゲン化
炭化水素類:ジエチルエーテル,テトラヒドロフランの
ようなエーテル類:ベンゼン,トルエンのような炭化水
素類またはアセトニトリル,プロピオニトリルのような
ニトリル類が好適である。
The solvent used is not particularly limited as long as it does not participate in this reaction, but halogenated hydrocarbons such as methylene chloride, chloroform and dichloroethane: diethyl ether, ethers such as tetrahydrofuran: benzene Hydrocarbons such as toluene and nitriles such as acetonitrile and propionitrile are preferred.

【0037】反応温度は通常−78℃乃至50℃であ
り、好適には−30℃乃至30℃である。反応時間は原
料化合物および反応試剤により異なるが通常は5分間〜
3時間である。
The reaction temperature is usually -78 ° C to 50 ° C, preferably -30 ° C to 30 ° C. The reaction time varies depending on the raw material compounds and reaction reagents, but is usually 5 minutes
3 hours.

【0038】反応終了後目的化合物は過剰の酸塩化物を
アルコール類によって分解した後常法に従って反応混合
物から単離することができる。たとえば、反応混合物に
水を加え、水と混合しない有機溶媒例えば前記の反応溶
媒または酢酸エチルで目的化合物(4)を抽出し、抽出
液より溶媒を留去し、更に必要ならばカラムクロマトグ
ラフィー等により精製し、純品を得ることができる。
After completion of the reaction, the desired compound can be isolated from the reaction mixture by a conventional method after decomposing excess acid chloride with alcohol. For example, water is added to the reaction mixture, the target compound (4) is extracted with an organic solvent immiscible with water, such as the above-mentioned reaction solvent or ethyl acetate, the solvent is distilled off from the extract, and column chromatography, etc., if necessary. Can be purified to obtain a pure product.

【0039】第2工程 一般式(IV)を有する化合物を2〜6モル当量の3価の
リン化合物(V)と無溶媒であるいは溶媒中反応させる
とホスホラン(VI)が得られる。
Step 2 The compound having the general formula (IV) is reacted with 2 to 6 molar equivalents of the trivalent phosphorus compound (V) without solvent or in a solvent to obtain phosphorane (VI).

【0040】使用される溶媒としては、本反応に関与し
ないものであれば特に限定はないが、ベンゼン,トルエ
ン,キシレンのような炭化水素類:クロロホルム,塩化
メチレン,1,2−ジクロロエタンのようなハロゲン化
炭素類、テトラヒドロフラン,ジオキサンのようなエー
テル類、アセトニトリルのようなニトリル類、酢酸エチ
ルのようなエステル類、ジメチルホルムアミドなどのア
ミド類である。
The solvent used is not particularly limited as long as it does not participate in this reaction, but hydrocarbons such as benzene, toluene, xylene: chloroform, methylene chloride, 1,2-dichloroethane, etc. Examples are carbon halides, ethers such as tetrahydrofuran and dioxane, nitriles such as acetonitrile, esters such as ethyl acetate, and amides such as dimethylformamide.

【0041】反応温度は通常−10℃乃至100℃であ
り、好適には0℃乃至100℃である。反応時間は原料
化合物および反応試剤により異なるが通常は10分間〜
30時間である。
The reaction temperature is usually -10 ° C to 100 ° C, preferably 0 ° C to 100 ° C. The reaction time varies depending on the raw material compound and the reaction reagent, but is usually 10 minutes to
30 hours.

【0042】反応終了後、過剰のリン化合物(V)及び
その酸素付加物を減圧下留去することによりあるいはヘ
キサンなどの非極性溶媒を加えて生成物を沈殿させるこ
とによりホスホラン(VI)が得られる。
After completion of the reaction, phosphorous (VI) is obtained by distilling off excess phosphorus compound (V) and its oxygen adduct under reduced pressure or by adding a non-polar solvent such as hexane to precipitate the product. To be

【0043】このようにして得られた粗生成物のVIは精
製することなくそのまま次の工程に用いることができる
が、必要ならばカラムクロマトグラフィーなどを用いる
ことによって精製することができる。
The VI of the crude product thus obtained can be used as it is in the next step without purification, but if necessary, it can be purified by using column chromatography or the like.

【0044】第3工程 ホスホラン(VI)を加熱すると、化合物(Ia)が得ら
れる。
Third Step By heating the phosphorane (VI), the compound (Ia) is obtained.

【0045】使用される溶媒としては、本反応に関与し
ないものであれば特に限定はないがトルエン,キシレ
ン,メシチレンまたはクロロベンゼンなどの置換芳香族
炭化水素類があげられる。反応温度は通常100〜20
0℃であり、好適には120〜170℃である。反応時
間は原料化合物および反応試剤によって異るが通常は1
〜30時間である。
The solvent used is not particularly limited as long as it does not participate in this reaction, but substituted aromatic hydrocarbons such as toluene, xylene, mesitylene or chlorobenzene can be mentioned. The reaction temperature is usually 100 to 20.
It is 0 degreeC, Preferably it is 120-170 degreeC. The reaction time varies depending on the raw material compound and the reaction reagent, but is usually 1
~ 30 hours.

【0046】反応終了後、溶媒を留去し、残渣を再結晶
によりまたはクロマトグラフィーで精製し、化合物(I
a)が得られる。
After completion of the reaction, the solvent is distilled off and the residue is purified by recrystallization or by chromatography to give compound (I
a) is obtained.

【0047】B法は一般式(Ia)を有する化合物を酸
化して化合物(Ib)を合成する方法である。
Method B is a method of oxidizing compound having the general formula (Ia) to synthesize compound (Ib).

【0048】第4工程 化合物(Ia)を酸化剤と反応させるとS−オキシド
(Ib)が得られる。酸化剤としては、m−クロロ過安
息香酸、過酢酸、過酸化水素、t−ブチルヒドロペルオ
キシドなどの過酸化物があるが、好適にはm−クロロ過
安息香酸、t−ブチルヒドロペルオキシドである。t−
ブチルヒドロペルオキシドを用いる場合反応の触媒とし
て、バナジルアセチルアセトナート〔VO(acac)
2 〕、モリブデンアセチルアセトナートなどを用いるこ
とができるが、好適にはバナジルアセチルアセトナート
をあげることができる。また本反応に関与することによ
り生成する過酸化物由来の酸性物質を除去するために、
アルカリ金属炭酸塩あるいはその水溶液の存在下、酸化
反応を行うことができる。使用される溶媒としては、本
反応に関与しないものなら特に限定はなく、メタノー
ル,エタノールなどのアルコール類、ジクロロメタン,
クロロホルム,1,2−ジクロロエタンのようなハロゲ
ン化炭素類、などがあげられ、好適にはハロゲン化炭素
である。反応温度は10〜50℃で行われ、好適には0
〜25℃である。反応時間は反応温度などによって異な
るが、通常は30分間〜6時間である。
Step 4 S-oxide (Ib) is obtained by reacting compound (Ia) with an oxidizing agent. Examples of the oxidizing agent include peroxides such as m-chloroperbenzoic acid, peracetic acid, hydrogen peroxide, and t-butylhydroperoxide, but m-chloroperbenzoic acid and t-butylhydroperoxide are preferable. . t-
When butyl hydroperoxide is used as a catalyst for the reaction, vanadyl acetylacetonate [VO (acac)
2 ] and molybdenum acetylacetonate can be used, but vanadyl acetylacetonate is preferable. Further, in order to remove the acidic substance derived from peroxide generated by participating in this reaction,
The oxidation reaction can be carried out in the presence of an alkali metal carbonate or an aqueous solution thereof. The solvent used is not particularly limited as long as it does not participate in this reaction, and alcohols such as methanol and ethanol, dichloromethane,
Examples thereof include halogenated carbons such as chloroform and 1,2-dichloroethane, and preferably halogenated carbons. The reaction temperature is 10 to 50 ° C., preferably 0.
~ 25 ° C. The reaction time varies depending on the reaction temperature and the like, but is usually 30 minutes to 6 hours.

【0049】反応終了後、過剰の酸化物を分解するため
に10%亜硫酸ナトリウムのような還元剤を加え、塩化
メチレンなどの溶媒で希釈し、得られる有機溶媒層を水
洗、乾燥した後、有機溶剤を留去することによって得ら
れる。
After completion of the reaction, a reducing agent such as 10% sodium sulfite is added to decompose excess oxide, and the mixture is diluted with a solvent such as methylene chloride. The obtained organic solvent layer is washed with water and dried. Obtained by distilling off the solvent.

【0050】残渣を再結晶によりまたはクロマトグラフ
ィーで精製し化合物(Ib)が得られる。
The residue is purified by recrystallization or by chromatography to obtain the compound (Ib).

【0051】C法は一般式(Ib)を有する化合物をさ
らに酸化して化合物(Ic)を合成する方法である。
Method C is a method for synthesizing compound (Ic) by further oxidizing the compound having general formula (Ib).

【0052】第5工程は第4工程と同様にして行うこと
ができる。また第5工程で得られる化合物(Ic)は化
合物(Ia)より直接過剰の酸化剤を用いても合成でき
る。
The fifth step can be performed in the same manner as the fourth step. The compound (Ic) obtained in the fifth step can also be synthesized by directly using an excess of an oxidizing agent as compared with the compound (Ia).

【0053】D法 は化合物(Id)の水酸基の保護基
1 を除去する工程で公知の方法(T.W.Green and P.G.
M Wuts, “Protective Groups in Organic Synthesis.
2ndEdition ”John Wiley and Sons,Inc.,1991,p10)に
よって達成される。
Method D is a known method (TWGreen and PG) in the step of removing the protective group R 1 for the hydroxyl group of compound (Id).
M Wuts, “Protective Groups in Organic Synthesis.
2ndEdition ”John Wiley and Sons, Inc., 1991, p10).

【0054】本発明化合物Iに含まれる化合物(Ia)
から導かれた(Ib)及び(Ic)はマグネシウム塩存
在下、例えばシクロヘキシルイソプロピル マグネシウ
ムブロミドまたはジイソプロピルアミンと臭化マグネシ
ウム エーテル錯体の存在下適当なメルカプタン(R10
SH)と付加脱離反応を行い好収率で化合物 VIIに変換
される。
Compound (Ia) included in Compound I of the present invention
(Ib) and (Ic) derived from the above are suitable mercaptans (R 10 ) in the presence of magnesium salts, for example, cyclohexylisopropyl magnesium bromide or diisopropylamine and magnesium bromide ether complex.
It is converted to compound VII in good yield by addition-elimination reaction with SH).

【0055】[0055]

【化9】 [Chemical 9]

【0056】R10SHとしては、例えばExamples of R 10 SH include

【0057】[0057]

【化10】 [Chemical 10]

【0058】などをあげることができる。And the like.

【0059】[0059]

【発明の効果】本発明化合物Iに含まれる化合物(I
a)から導かれた化合物(Ib)及び(Ic)を好収率
で化合物(VII )に変換することができた。
INDUSTRIAL APPLICABILITY The compounds (I
The compounds (Ib) and (Ic) derived from a) could be converted to the compound (VII) in good yield.

【0060】ここに得られた(VII )のR1 が水酸基の
保護基のときには常法によりこれを除去し、さらにカル
ボキシ基の保護基R4 を除去することによりすぐれた抗
菌活性を示す1−置換カルバペネムに導くことができ
る。従って本発明化合物(I)は1−置換カルバペネム
抗生物質合成の有用な中間体である。
When R 1 of (VII) thus obtained is a hydroxyl-protecting group, it is removed by a conventional method, and further, a carboxyl-protecting group R 4 is removed to exhibit excellent antibacterial activity. Can lead to substituted carbapenems. Therefore, the compound (I) of the present invention is a useful intermediate in the synthesis of 1-substituted carbapenem antibiotics.

【0061】[0061]

【実施例】【Example】

実施例1 (1R,5S,6S)−2−(2−ジエチル
カルバモイルフェニルチオ)−1−メチル−6−
〔(R)−1−トリメチルシリルオキシエチル〕−1−
カルバペン−2−エム−3−カルボン酸4−ニトロベン
ジルエステル
Example 1 (1R, 5S, 6S) -2- (2-diethylcarbamoylphenylthio) -1-methyl-6-
[(R) -1-Trimethylsilyloxyethyl] -1-
Carbapene-2-em-3-carboxylic acid 4-nitrobenzyl ester

【0062】[0062]

【化11】 [Chemical 11]

【0063】参考例1の化合物492mg(1.09m
mol)とトリエチルアミン0.46ml(3.30m
mol)の塩化メチレン8ml溶液を塩−氷浴で冷却
し、4−ニトロベンジルオキシオキサリルクロリド79
7mg(3.27mmol)を加え同温度で15分間反
応させた。さらにイソプロパノール0.25ml(3.
27mmol)を加え10分間同温度で撹拌し過剰の酸
クロリドを分解した。反応液を酢酸エチルで希釈し、水
で2回、飽和食塩水で2回洗浄した。溶媒を留去し、得
られた残渣をトルエンに懸濁させ、不溶物を濾去し除い
た。トルエンを留去し、残渣にジプロピルエチルホスホ
ナイト784mg(4.40mmol)を加え、室温で
140分間撹拌した。過剰の試薬を留去し残渣をキシレ
ン65mlに溶かし3時間加熱還流した。溶媒を留去し
残渣をシリカゲル50gを用いるカラムクロマトグラフ
ィーに付し酢酸エチル−ヘキサン(1:2)で溶出し、
少量の不純物を含む目的物を得た。これをさらに同一条
件で精製し目的化合物535mg(78%)が得られ、
このものをイソプロピルエーテルで再結するとmp20
2〜203℃の無色結晶が得られた。
492 mg (1.09 m) of the compound of Reference Example 1
mol) and triethylamine 0.46 ml (3.30 m)
Mol) in 8 ml of methylene chloride was cooled in a salt-ice bath to give 4-nitrobenzyloxyoxalyl chloride 79
7 mg (3.27 mmol) was added and reacted at the same temperature for 15 minutes. Furthermore, 0.25 ml of isopropanol (3.
27 mmol) was added and the mixture was stirred for 10 minutes at the same temperature to decompose excess acid chloride. The reaction solution was diluted with ethyl acetate and washed twice with water and twice with saturated saline. The solvent was evaporated, the obtained residue was suspended in toluene, and the insoluble material was removed by filtration. Toluene was distilled off, 784 mg (4.40 mmol) of dipropylethylphosphonite was added to the residue, and the mixture was stirred at room temperature for 140 minutes. The excess reagent was distilled off, the residue was dissolved in 65 ml of xylene, and the mixture was heated under reflux for 3 hours. The solvent was distilled off, and the residue was subjected to column chromatography using 50 g of silica gel and eluted with ethyl acetate-hexane (1: 2),
The target product containing a small amount of impurities was obtained. This was further purified under the same conditions to obtain 535 mg (78%) of the target compound,
Mp20 when re-bonded with isopropyl ether
Colorless crystals of 2 to 203 ° C were obtained.

【0064】IRスペクトル (KBr)cm-1:1761,1695,163
0,1342,1207 NMR スペクトル(270MHz,CDCl3)δppm:0.10(9H,s),1.01
(3H,t,J=7Hz),0.95-1.20(6H,m),1.20(3H,d,J=6Hz),3.06
(2H,q,J=7Hz),3.05-3.28(3H,m),3.45-3.80(1H,brs),4.1
8-4.25(2H,m),5.27(1H,d,J=14Hz),5.47(1H,d,J=14Hz),
7.32-7.65(4H,m),7.68(2H,d,J=9Hz),8.21(2H,d,J=9Hz) マススペクトル(m/z):625(M+,C31H39N3O7SSi) 実施例2 (1R,5S,6S)−2−(2−ジエチル
カルバモイルフェニルチオ)−1−メチル−6−
〔(R)−1−t−ブチルジメチルシリルオキシエチ
ル〕−1−カルバペン−2−エム−3−カルボン酸4−
ニトロベンジルエステル
IR spectrum (KBr) cm -1 : 1761,1695,163
0,1342,1207 NMR spectrum (270MHz, CDCl 3 ) δppm: 0.10 (9H, s), 1.01
(3H, t, J = 7Hz), 0.95-1.20 (6H, m), 1.20 (3H, d, J = 6Hz), 3.06
(2H, q, J = 7Hz), 3.05-3.28 (3H, m), 3.45-3.80 (1H, brs), 4.1
8-4.25 (2H, m), 5.27 (1H, d, J = 14Hz), 5.47 (1H, d, J = 14Hz),
7.32-7.65 (4H, m), 7.68 (2H, d, J = 9Hz), 8.21 (2H, d, J = 9Hz) Mass spectrum (m / z): 625 (M + , C 31 H 39 N 3 O 7 SSi) Example 2 (1R, 5S, 6S) -2- (2-diethylcarbamoylphenylthio) -1-methyl-6-
[(R) -1-t-Butyldimethylsilyloxyethyl] -1-carbapene-2-em-3-carboxylic acid 4-
Nitrobenzyl ester

【0065】[0065]

【化12】 [Chemical 12]

【0066】参考例1に使用した原料を実施例1と同様
に反応、処理すると、80%の収率で目的化合物が得ら
れ、これをイソプロピルエーテルで再結するとmp16
6〜166.5℃の結晶が得られた。
When the raw material used in Reference Example 1 was reacted and treated in the same manner as in Example 1, the target compound was obtained in a yield of 80%, which was recombined with isopropyl ether to give mp16.
Crystals of 6 to 166.5 ° C were obtained.

【0067】IRスペクトル (nujol)cm-1:1762,1693,16
33,1340,1210 NMR スペクトル(270MHz,CDCl3)δppm:0.06(6H,s),0.84
(9H,s),1.01(3H,t,J=7Hz),0.93-1.20(6H,m),1.16(3H,d,
J=6Hz),3.00-3.30(3H,m),3.07(2H,q,J=7Hz),3.40-3.90
(1H,m),4.21-4.33(2H,m),5.28(1H,d,J=14Hz),5.44(1H,
d,J=14Hz),7.27-7.65(4H,m),7.67(2H,d,J=9Hz),8.21(2
H,d of t,J=9Hz) マススペクトル(m/z):667(M+,C34H45N3O7SSi) 実施例3 (1R,5S,6S)−2−〔2−(2H−
1,3,4,5,6,7−ヘキサヒドロ1−アゼピニ
ル)カルボニルフェニルチオ〕−1−メチル−6−
〔(R)−1−t−ブチルジメチルシリルオキシエチ
ル〕−1−カルバペン−2−エム−3−カルボン酸4−
ニトロベンジルエステル
IR spectrum (nujol) cm −1 : 1762,1693,16
33,1340,1210 NMR spectrum (270MHz, CDCl 3 ) δppm: 0.06 (6H, s), 0.84
(9H, s), 1.01 (3H, t, J = 7Hz), 0.93-1.20 (6H, m), 1.16 (3H, d,
J = 6Hz), 3.00-3.30 (3H, m), 3.07 (2H, q, J = 7Hz), 3.40-3.90
(1H, m), 4.21-4.33 (2H, m), 5.28 (1H, d, J = 14Hz), 5.44 (1H,
d, J = 14Hz), 7.27-7.65 (4H, m), 7.67 (2H, d, J = 9Hz), 8.21 (2
H, d of t, J = 9 Hz) Mass spectrum (m / z): 667 (M + , C 34 H 45 N 3 O 7 SSi) Example 3 (1R, 5S, 6S) -2- [2- ( 2H-
1,3,4,5,6,7-Hexahydro1-azepinyl) carbonylphenylthio] -1-methyl-6-
[(R) -1-t-Butyldimethylsilyloxyethyl] -1-carbapene-2-em-3-carboxylic acid 4-
Nitrobenzyl ester

【0068】[0068]

【化13】 [Chemical 13]

【0069】特願平4−174099号公報の実施例9
の化合物を実施例1と同様に反応、処理すると目的化合
物が得られ、これをイソプロピルエーテルで再結すると
mp210〜211℃の結晶が得られた。
Example 9 of Japanese Patent Application No. 4-174099
The target compound was obtained by reacting and treating the compound of Example 1 in the same manner as in Example 1, and recrystallized with isopropyl ether to give crystals of mp 210 to 211 ° C.

【0070】IRスペクトル (KBr)cm-1:1757,1700,163
2,1341,1212,1138 NMR スペクトル(270MHz,CDCl3)δppm:0.06(6H,s),0.85
(9H,s),0.95-1.08(3H,m),1.16(3H,d,J=6Hz),1.40-1.85
(8H,m),3.04-3.34(5H,m),3.45-3.65(1H,brs),4.20-4.36
(2H,m),5.29(1H,d,J=14Hz),5.46(1H,d,J=14Hz),7.30-7.
65(4H,m),7.68(2H,d,J=9Hz),8.22(2H,d,J=9Hz) マススペクトル(m/z):693(M+,C36H47N3O7SSi) 実施例4 (1R,5S,6S)−2−(2−ジエチル
カルバモイルフェニルチオ)−1−メチル−6−
〔(R)−1−ヒドロキシエチル〕−1−カルバペン−
2−エム−3−カルボン酸4−ニトロベンジルエステル
IR spectrum (KBr) cm −1 : 1757,1700,163
2,1341,1212,1138 NMR spectrum (270MHz, CDCl 3 ) δppm: 0.06 (6H, s), 0.85
(9H, s), 0.95-1.08 (3H, m), 1.16 (3H, d, J = 6Hz), 1.40-1.85
(8H, m), 3.04-3.34 (5H, m), 3.45-3.65 (1H, brs), 4.20-4.36
(2H, m), 5.29 (1H, d, J = 14Hz), 5.46 (1H, d, J = 14Hz), 7.30-7.
65 (4H, m), 7.68 (2H, d, J = 9Hz), 8.22 (2H, d, J = 9Hz) Mass spectrum (m / z): 693 (M + , C 36 H 47 N 3 O 7 SSi ) Example 4 (1R, 5S, 6S) -2- (2-diethylcarbamoylphenylthio) -1-methyl-6-
[(R) -1-hydroxyethyl] -1-carbapene-
2-M-3-carboxylic acid 4-nitrobenzyl ester

【0071】[0071]

【化14】 [Chemical 14]

【0072】実施例1の化合物1.072g(1.71
mmol)のメタノール−塩化メチレン(2:1)30
ml溶液にクエン酸の水和物41mg(0.195mm
ol)を加え室温で20分間撹拌した。反応液を濃縮
し、得られた残渣をシリカゲル25gを用いるカラムク
ロマトグラフィーに付し、酢酸エチルで溶出し無色の泡
状物質970mg(定量的収率)を得た。
1.072 g (1.71 g) of the compound of Example 1
mmol) methanol-methylene chloride (2: 1) 30
41 mg of citric acid hydrate (0.195 mm
ol) was added and the mixture was stirred at room temperature for 20 minutes. The reaction solution was concentrated, and the obtained residue was subjected to column chromatography using 25 g of silica gel and eluted with ethyl acetate to obtain 970 mg (quantitative yield) of a colorless foamy substance.

【0073】IRスペクトル (neat)cm-1 :3600〜3200(b
r),1771,1707,1612,1352,1207 NMR スペクトル(270MHz,CDCl3)δppm:1.00(3H,t,J=7H
z),0.94-1.15(6H,m),1.30(3H,d,J=6Hz),3.05(2H,q,J=7H
z),3.10-3.28(3H,m),3.45-3.80(1H,brs),4.20(1H,quin
t,J=7Hz),4.25(1H,dd,J=2Hz,9Hz),5.27(1H,d,J=14Hz),
5.48(1H,d,J=14Hz),7.31-7.65(4H,m),7.67(2H,d,J=9H
z),8.22(2H,d,J=9Hz) マススペクトル(m/z):553(M+,C28H31N3O7S) 実施例5 (1R,5S,6S)−2−(2−ジエチル
カルバモイルフェニルスルフィニル)−1−メチル−6
−〔(R)−1−トリメチルシリルオキシエチル〕−1
−カルバペン−2−エム−3−カルボン酸4−ニトロベ
ンジルエステル
IR spectrum (neat) cm −1 : 3600 to 3200 (b
r), 1771,1707,1612,1352,1207 NMR spectrum (270MHz, CDCl 3 ) δppm: 1.00 (3H, t, J = 7H
z), 0.94-1.15 (6H, m), 1.30 (3H, d, J = 6Hz), 3.05 (2H, q, J = 7H
z), 3.10-3.28 (3H, m), 3.45-3.80 (1H, brs), 4.20 (1H, quin
t, J = 7Hz), 4.25 (1H, dd, J = 2Hz, 9Hz), 5.27 (1H, d, J = 14Hz),
5.48 (1H, d, J = 14Hz), 7.31-7.65 (4H, m), 7.67 (2H, d, J = 9H
z), 8.22 (2H, d , J = 9Hz) Mass Spectrum (m / z): 553 ( M +, C 28 H 31 N 3 O 7 S) Example 5 (1R, 5S, 6S) -2- ( 2-Diethylcarbamoylphenylsulfinyl) -1-methyl-6
-[(R) -1-trimethylsilyloxyethyl] -1
-Carbapene-2-em-3-carboxylic acid 4-nitrobenzyl ester

【0074】[0074]

【化15】 [Chemical 15]

【0075】実施例1の化合物304mg(0.486
mmol)の塩化メチレン6ml溶液に重曹122mg
(1.45mmol)を加え、氷冷撹拌下純度80%の
3−クロロ過安息香酸105mg(0.487mmo
l)を加え同温度で一時間撹拌した。反応液を塩化メチ
レンで希釈し、氷冷した希重曹水で洗浄した。溶媒を留
去して得られる残渣をシリカゲル25gを用いるカラム
クロマトグラフィーに付し、酢酸エチル−ヘキサン
(2:1)で溶出し泡状物質として目的化合物260m
g(83%)を得た。
304 mg of the compound of Example 1 (0.486
122 mg of baking soda in 6 ml of methylene chloride solution.
(1.45 mmol) was added, and 105 mg (0.487 mmo) of 3-chloroperbenzoic acid having a purity of 80% under stirring with ice cooling.
1) was added and the mixture was stirred at the same temperature for 1 hour. The reaction solution was diluted with methylene chloride and washed with ice-cooled dilute aqueous sodium hydrogen carbonate. The residue obtained by evaporating the solvent was subjected to column chromatography using 25 g of silica gel and eluted with ethyl acetate-hexane (2: 1) to give 260 m of the target compound as a foamy substance.
g (83%) was obtained.

【0076】IRスペクトル (film)cm-1 :1788,1734,16
30,1522,1061 NMR スペクトル(270MHz,CDCl3)δppm: 0.08(5.4H,s),0.
10(3.6H,s),1.04-1.27(12H,m),2.98-3.53(5.6H,m),3.67
(0.4H,d of q,J=11Hz,7Hz),4.16-4.23(1H,m),4.26(0.6
H,dd,J=10Hz,3Hz),4.34(0.4H,dd,J=10Hz,3Hz),5.35(0.4
H,d,J=14Hz),5.38(0.6H,d,J=14Hz),5.46(0.4H,d,J=14H
z),5.50(0.6H,d,J=14Hz),7.27-7.36(1H,m),7.50-7.73(4
H,m),7.84-7.90(0.4H,m),8.15-8.26(2.6H,m) マススペクトル(m/z):641(M+,C31H39N3O8SSi) 実施例6 (1R,5S,6S)−2−(2−ジエチル
カルバモイルフェニルスルフィニル)−1−メチル−6
−〔(R)−1−t−ブチルジメチルシリルオキシエチ
ル〕−1−カルバペン−2−エム−3−カルボン酸4−
ニトロベンジルエステル
IR spectrum (film) cm −1 : 1788,1734,16
30,1522,1061 NMR spectrum (270MHz, CDCl 3 ) δppm: 0.08 (5.4H, s), 0.
10 (3.6H, s), 1.04-1.27 (12H, m), 2.98-3.53 (5.6H, m), 3.67
(0.4H, d of q, J = 11Hz, 7Hz), 4.16-4.23 (1H, m), 4.26 (0.6
H, dd, J = 10Hz, 3Hz), 4.34 (0.4H, dd, J = 10Hz, 3Hz), 5.35 (0.4
H, d, J = 14Hz), 5.38 (0.6H, d, J = 14Hz), 5.46 (0.4H, d, J = 14H)
z), 5.50 (0.6H, d, J = 14Hz), 7.27-7.36 (1H, m), 7.50-7.73 (4
H, m), 7.84-7.90 (0.4H , m), 8.15-8.26 (2.6H, m) mass spectrum (m / z): 641 ( M +, C 31 H 39 N 3 O 8 SSi) Example 6 (1R, 5S, 6S) -2- (2-Diethylcarbamoylphenylsulfinyl) -1-methyl-6
-[(R) -1-t-Butyldimethylsilyloxyethyl] -1-carbapene-2-em-3-carboxylic acid 4-
Nitrobenzyl ester

【0077】[0077]

【化16】 [Chemical 16]

【0078】実施例2の化合物を実施例5と同様に反
応、処理すると目的化合物を収率87%で泡状物質とし
て得た。
When the compound of Example 2 was reacted and treated in the same manner as in Example 5, the target compound was obtained as a foamy substance in a yield of 87%.

【0079】IRスペクトル (nujol)cm-1:1788,1735,16
30,1523,1058 NMR スペクトル(270MHz,CDCl3)δppm:0.03,0.04,0.05,
0.06(6H,each s),0.83(4.5H,s),0.84(4.5H,s),1.05-1.2
7(12H,m),2.98-3.56(5.5H,m),3.59(0.5H,d of q,J=10H
z,7Hz),4.20-4.38(1H,m),4.30(0.5H,dd,J=11Hz,3Hz),4.
39(0.5H,dd,J=11Hz,3Hz),5.34(0.5H,d,J=14Hz),5.38(0.
5H,d,J=14Hz),5.45(0.5H,d,J=14Hz),5.49(0.5H,d,J=14H
z),7.29-7.36(1H,m),7.50-7.71(4H,m),7.85-7.89(0.5H,
m),8.15-8.25(2.5H,m) マススペクトル(m/z):683(M+,C34H45N3O8SSi) 実施例7 (1R,5S,6S)−2−(2−ジエチル
カルバモイルフェニルスルフィニル)−1−メチル−6
−〔(R)−ヒドロキシエチル〕−1−カルバペン−2
−エム−3−カルボン酸4−ニトロベンジルエステル
IR spectrum (nujol) cm −1 : 1788,1735,16
30,1523,1058 NMR spectrum (270MHz, CDCl 3 ) δppm: 0.03,0.04,0.05,
0.06 (6H, each s), 0.83 (4.5H, s), 0.84 (4.5H, s), 1.05-1.2
7 (12H, m), 2.98-3.56 (5.5H, m), 3.59 (0.5H, d of q, J = 10H
z, 7Hz), 4.20-4.38 (1H, m), 4.30 (0.5H, dd, J = 11Hz, 3Hz), 4.
39 (0.5H, dd, J = 11Hz, 3Hz), 5.34 (0.5H, d, J = 14Hz), 5.38 (0.
5H, d, J = 14Hz), 5.45 (0.5H, d, J = 14Hz), 5.49 (0.5H, d, J = 14H)
z), 7.29-7.36 (1H, m), 7.50-7.71 (4H, m), 7.85-7.89 (0.5H,
m), 8.15-8.25 (2.5H, m ) mass spectrum (m / z): 683 ( M +, C 34 H 45 N 3 O 8 SSi) Example 7 (1R, 5S, 6S) -2- (2 -Diethylcarbamoylphenylsulfinyl) -1-methyl-6
-[(R) -hydroxyethyl] -1-carbapene-2
-M-3-carboxylic acid 4-nitrobenzyl ester

【0080】[0080]

【化17】 [Chemical 17]

【0081】実施例4の化合物554mg(1.00m
mol)の塩化メチレン10ml溶液を氷冷し、1M重
曹水1.5ml(1.5mmol)、80%m−クロロ
過安息香酸215mg(1.00mmol)を順次加え
同温度で90分間撹拌した。反応液に亜硫酸ナトリウム
水溶液を加え10分間撹拌し反応を終結させた。反応液
を塩化メチレンで希釈し、氷冷した重曹水で洗浄し、濃
縮した。残渣をシリカゲル50gを用いるカラムクロマ
トグラフィーに付し酢酸エチルで溶出して、極性の低い
目的化合物145mg(25%)(S−Oの配位による
異性体)及び極性の高い目的化合物96mg(17%)
をそれぞれ泡状物質とした。
554 mg of the compound of Example 4 (1.00 m
10 ml of a methylene chloride solution in 10 ml of methylene chloride was ice-cooled, 1.5 ml (1.5 mmol) of 1M aqueous sodium hydrogen carbonate solution and 215 mg (1.00 mmol) of 80% m-chloroperbenzoic acid were sequentially added, and the mixture was stirred at the same temperature for 90 minutes. Aqueous sodium sulfite solution was added to the reaction solution and stirred for 10 minutes to terminate the reaction. The reaction mixture was diluted with methylene chloride, washed with ice-cold aqueous sodium hydrogen carbonate, and concentrated. The residue was subjected to column chromatography using 50 g of silica gel and eluted with ethyl acetate to obtain 145 mg (25%) of the target compound with low polarity (isomer with S—O coordination) and 96 mg (17% of target compound with high polarity). )
Respectively as a foamy substance.

【0082】IRスペクトル (film)cm-1 :低極性s−オ
キシド,3500-3300,1786,1732,1624,1522,1200,1061; 高
極性s−オキシド,3500-3300,1786,1734,1624,1522,119
8,1061 NMR スペクトル(270MHz,CDCl3)δppm:低極性s−オキシ
ド,1.02-1.11(6H,m),1.24(6H,t,J=7Hz),3.01(1H,d of
q,J=10Hz,7Hz),3.12(2H,q,J=7Hz),3.18-3.30(1H,m),3.3
2(1H,dd,J=3Hz,6Hz),3.39-3.52(1H,m),4.19(1H,quint,6
Hz),4.28(1H,dd,J=3Hz,10Hz),5.38(1H,d,J=14Hz),5.52
(1H,d,J=14Hz),7.33(1H,dd,J=1Hz,8Hz),7.58(1H,d of
t,J=1Hz,8Hz),7.66(1H,d of t,J=1Hz,8Hz),7.70(2H,d,J
=9Hz),8.16(1H,dd,J=1Hz,8Hz),8.24(2H,d,J=9Hz);高極
性s−オキシド,0.83(3H,d,J=7Hz),1.09(3H,t,J=7Hz),
1.18(3H,t,J=7Hz),1.28(3H,d,J=6Hz),3.18(2H,q,J=7H
z),3.20-3.35(1H,m),3.40-3.53(1H,m),3.47(1H,dd,J=3H
z,6Hz),3.70(1H,d of q,J=10Hz,7Hz),4.25(1H,quint,6H
z),4.38(1H,dd,J=3Hz,10Hz),5.34(1H,d,J=13Hz),5.48(1
H,d,J=13Hz),7.28-7.32(1H,m),7.48-7.56(2H,m),7.65(2
H,d,J=9Hz),7.85-7.91(1H,m),8.22(2H,d,J=9Hz) マススペクトル(m/z): 高極性s−オキシド,551(M+-H
2O) 実施例8 (1R,5S,6S)−2−〔2−(2H−
1,3,4,5,6,7−ヘキサヒドロ−1−アゼピニ
ル)カルボニルスルフェニルスルフィニル)−1−メチ
ル−6−〔(R)−1−t−ブチルジメチルシリルオキ
シエチル〕−1−カルバペン−2−エム−3−カルボン
酸4−ニトロベンジルエステル
IR spectrum (film) cm -1 : low polar s-oxide, 3500-3300,1786,1732,1624,1522,1200,1061; high polar s-oxide, 3500-3300,1786,1734,1624, 1522,119
8,1061 NMR spectrum (270 MHz, CDCl 3 ) δppm: low-polarity s-oxide, 1.02-1.11 (6H, m), 1.24 (6H, t, J = 7Hz), 3.01 (1H, d of
q, J = 10Hz, 7Hz), 3.12 (2H, q, J = 7Hz), 3.18-3.30 (1H, m), 3.3
2 (1H, dd, J = 3Hz, 6Hz), 3.39-3.52 (1H, m), 4.19 (1H, quint, 6
Hz), 4.28 (1H, dd, J = 3Hz, 10Hz), 5.38 (1H, d, J = 14Hz), 5.52
(1H, d, J = 14Hz), 7.33 (1H, dd, J = 1Hz, 8Hz), 7.58 (1H, d of
t, J = 1Hz, 8Hz), 7.66 (1H, d of t, J = 1Hz, 8Hz), 7.70 (2H, d, J
= 9Hz), 8.16 (1H, dd, J = 1Hz, 8Hz), 8.24 (2H, d, J = 9Hz); high polarity s-oxide, 0.83 (3H, d, J = 7Hz), 1.09 (3H, t , J = 7Hz),
1.18 (3H, t, J = 7Hz), 1.28 (3H, d, J = 6Hz), 3.18 (2H, q, J = 7H
z), 3.20-3.35 (1H, m), 3.40-3.53 (1H, m), 3.47 (1H, dd, J = 3H
z, 6Hz), 3.70 (1H, d of q, J = 10Hz, 7Hz), 4.25 (1H, quint, 6H
z), 4.38 (1H, dd, J = 3Hz, 10Hz), 5.34 (1H, d, J = 13Hz), 5.48 (1
H, d, J = 13Hz), 7.28-7.32 (1H, m), 7.48-7.56 (2H, m), 7.65 (2
H, d, J = 9Hz), 7.85-7.91 (1H, m), 8.22 (2H, d, J = 9Hz) Mass spectrum (m / z): high polarity s-oxide, 551 (M + -H)
2 O) Example 8 (1R, 5S, 6S) -2- [2- (2H-
1,3,4,5,6,7-Hexahydro-1-azepinyl) carbonylsulfenylsulfinyl) -1-methyl-6-[(R) -1-t-butyldimethylsilyloxyethyl] -1-carbapene- 2-M-3-carboxylic acid 4-nitrobenzyl ester

【0083】[0083]

【化18】 [Chemical 18]

【0084】実施例3で得られたの化合物を実施例5と
同様反応、処理すると目的化合物を泡状物質として得
た。収率89%。
The compound obtained in Example 3 was reacted and treated in the same manner as in Example 5 to obtain the target compound as a foamy substance. Yield 89%.

【0085】IRスペクトル (film)cm-1 :1790,1734,16
28,1524,1347,1061, NMR スペクトル(270MHz,CDCl3)δppm:0.03,0.04,0.05,
0.06(total 6H,each s),0.75(1.5H,d,J=7Hz),0.83(4.5
H,s),0.84(4.5H,s),1.13(1.5H,d,J=6Hz),1.16(1.5H,d,J
=6Hz),1.28(1.5H,d,J=7Hz),1.44-1.80(8H,m),3.00(0.5
H,d of q,J=10Hz,7Hz),3.11-3.37(3.5H,m),3.41-3.50(1
H,m),3.60-3.77(1H,m),4.19-4.31(1.5H,m),4.38(0.5H,d
d,J=10Hz,3Hz),5.33(0.5H,d,J=14Hz),5.40(0.5H,d,J=14
Hz),5.46(0.5H,d,J=14Hz),5.49(0.5H,d,J=14Hz),7.27-
7.32(0.5H,m),7.36(0.5H,dd,J=7Hz,1Hz),7.48-7.60(1.5
H,m),7.63-7.73(2.5H,m),7.93-7.96(0.5H,m,),8.15(0.5
H,dd,J=8Hz,1Hz),8.22(1H,d,J=9Hz),8.23(1H,d,J=9Hz) マススペクトル(m/z):709(M+,C36H47N3O8SSi) 実施例9 (1R,5S,6S)−2−(2−ジエチル
カルバモイルフェニルスルホニル)−1−メチル−6−
〔(R)−1−t−ブチルジメチルシリルオキシエチ
ル〕−1−カルバペン−2−エム−3−カルボン酸4−
ニトロベンジルエステル
IR spectrum (film) cm −1 : 1790, 1734, 16
28,1524,1347,1061, NMR spectrum (270 MHz, CDCl 3 ) δppm: 0.03, 0.04, 0.05,
0.06 (total 6H, each s), 0.75 (1.5H, d, J = 7Hz), 0.83 (4.5
H, s), 0.84 (4.5H, s), 1.13 (1.5H, d, J = 6Hz), 1.16 (1.5H, d, J
= 6Hz), 1.28 (1.5H, d, J = 7Hz), 1.44-1.80 (8H, m), 3.00 (0.5
H, d of q, J = 10Hz, 7Hz), 3.11-3.37 (3.5H, m), 3.41-3.50 (1
H, m), 3.60-3.77 (1H, m), 4.19-4.31 (1.5H, m), 4.38 (0.5H, d
d, J = 10Hz, 3Hz), 5.33 (0.5H, d, J = 14Hz), 5.40 (0.5H, d, J = 14
Hz), 5.46 (0.5H, d, J = 14Hz), 5.49 (0.5H, d, J = 14Hz), 7.27-
7.32 (0.5H, m), 7.36 (0.5H, dd, J = 7Hz, 1Hz), 7.48-7.60 (1.5
H, m), 7.63-7.73 (2.5H, m), 7.93-7.96 (0.5H, m,), 8.15 (0.5
H, dd, J = 8Hz, 1Hz), 8.22 (1H, d, J = 9Hz), 8.23 (1H, d, J = 9Hz) Mass spectrum (m / z): 709 (M + , C 36 H 47 N 3 O 8 SSi) Example 9 (1R, 5S, 6S) -2- (2-diethylcarbamoylphenylsulfonyl) -1-methyl-6-
[(R) -1-t-Butyldimethylsilyloxyethyl] -1-carbapene-2-em-3-carboxylic acid 4-
Nitrobenzyl ester

【0086】[0086]

【化19】 [Chemical 19]

【0087】実施例2の化合物157mg(0.235
mmol)の塩化メチレン3ml溶液を氷冷で冷却し重
曹78mg(0.93mmol)、80%m−クロロ過
安息香酸78mg(0.52mmol)を順次加えた。
同温度で20分、さらに室温3.5時間撹拌した後、亜
硫酸ナトリウム水溶液を加え、10分間撹拌し反応を終
結させた。反応液を塩化メチレンで希釈し、重曹水で洗
浄後、濃縮した。残渣をシリカゲル15gを用いるカラ
ムクロマトグラフィーに付し、酢酸エチル−ヘキサン
(4:6)で溶出し、泡状物質として目的化合物148
mg(90%)を得た。
157 mg (0.235) of the compound of Example 2
A solution of 3 mmol of methylene chloride in methylene chloride was cooled with ice, and 78 mg (0.93 mmol) of sodium bicarbonate and 78 mg (0.52 mmol) of 80% m-chloroperbenzoic acid were sequentially added.
After stirring at the same temperature for 20 minutes and further at room temperature for 3.5 hours, an aqueous sodium sulfite solution was added and the reaction was terminated by stirring for 10 minutes. The reaction mixture was diluted with methylene chloride, washed with aqueous sodium hydrogen carbonate, and concentrated. The residue was subjected to column chromatography using 15 g of silica gel and eluted with ethyl acetate-hexane (4: 6) to give the target compound 148 as a foamy substance.
mg (90%) was obtained.

【0088】IRスペクトル (film)cm-1 :1794,1748,16
36,1524,1320,1266,1161 NMR スペクトル(270MHz,CDCl3)δppm:0.03(3H,s),0.05
(3H,s),0.83(9H,s),1.06(3H,t,J=7Hz),1.16(3H,d,J=6H
z),1.20-1.43(6H,m),3.01-3.19(2H,m),3.24-3.84(4H,
m),4.19-4.28(1H,m),4.42-4.52(1H,m),5.39(2H,s),7.25
-7.34(1H,m),7.48-7.65(2H,m),7.62(2H,d,J=9Hz),8.11
(1H,d,J=8Hz),8.21(2H,d,J=9Hz) マススペクトル(m/z):700(M+(C34H45N3O9SSi)+1) 参考例1 (R)−2−〔(3S,4S)−3−
〔(R)−1−(トリメチルシリルオキシ)エチル〕−
2−オキソ−4−アゼチジニル〕チオプロピオン酸S−
2−ジエチルカルバモイルフェニルエステル
IR spectrum (film) cm −1 : 1794, 1748, 16
36,1524,1320,1266,1161 NMR spectrum (270MHz, CDCl 3 ) δppm: 0.03 (3H, s), 0.05
(3H, s), 0.83 (9H, s), 1.06 (3H, t, J = 7Hz), 1.16 (3H, d, J = 6H
z), 1.20-1.43 (6H, m), 3.01-3.19 (2H, m), 3.24-3.84 (4H,
m), 4.19-4.28 (1H, m), 4.42-4.52 (1H, m), 5.39 (2H, s), 7.25
-7.34 (1H, m), 7.48-7.65 (2H, m), 7.62 (2H, d, J = 9Hz), 8.11
(1H, d, J = 8Hz), 8.21 (2H, d, J = 9Hz) Mass spectrum (m / z): 700 (M + (C 34 H 45 N 3 O 9 SSi) +1) Reference example 1 ( R) -2-[(3S, 4S) -3-
[(R) -1- (trimethylsilyloxy) ethyl]-
2-oxo-4-azetidinyl] thiopropionic acid S-
2-diethylcarbamoylphenyl ester

【0089】[0089]

【化20】 [Chemical 20]

【0090】特願平3−172220に記載された化合
物(R)−2−〔(3S,4S)−3−〔(R)−1−
t−ブチルジメチルシリルオキシエチル〕−2−オキソ
−4−アゼチジニル〕チオプロピオン酸S−2−ジエチ
ルカルバモイルフェニルエステル1.002g(2.0
3mmol)のテトラヒドロフラン20ml溶液に2N
塩酸5mlを加え50℃で3時間加熱した。冷却後、反
応液を酢酸エチルで希釈し水と分配した。有機層を飽和
重曹水、水、飽和食塩水で順次洗浄した後、溶媒を留去
した。得られた脱シリル化物をテトラヒドロフラン10
mlに溶かし、トリエチルアミン0.60ml(4.3
0mmol)、トリメチルシリルクロリド0.53ml
を加え、室温で80分、40℃で100分間撹拌した。
冷却後反応液を酢酸エチルで希釈し、氷水で2回、さら
に飽和食塩水で洗浄し、溶媒を留去した。残渣をシリカ
ゲル100gを用いるカラムクロマトグラフィーに付し
酢酸エチル−ヘキサン(60〜80:100)で溶出し
泡状の標記化合物742mg(81%)を得た。
Compound (R) -2-[(3S, 4S) -3-[(R) -1-] described in Japanese Patent Application No. 3-172220
t-Butyldimethylsilyloxyethyl] -2-oxo-4-azetidinyl] thiopropionic acid S-2-diethylcarbamoylphenyl ester 1.002 g (2.0
3 mmol) in 20 ml of tetrahydrofuran solution
5 ml of hydrochloric acid was added and heated at 50 ° C. for 3 hours. After cooling, the reaction solution was diluted with ethyl acetate and partitioned with water. The organic layer was washed successively with saturated aqueous sodium hydrogen carbonate, water and saturated brine, and the solvent was evaporated. The obtained desilylated product was treated with tetrahydrofuran 10
Dissolve in 0.3 ml of triethylamine 0.60 ml (4.3
0 mmol), trimethylsilyl chloride 0.53 ml
Was added, and the mixture was stirred at room temperature for 80 minutes and at 40 ° C for 100 minutes.
After cooling, the reaction solution was diluted with ethyl acetate, washed twice with ice water and further washed with saturated saline, and the solvent was evaporated. The residue was subjected to column chromatography using 100 g of silica gel and eluted with ethyl acetate-hexane (60-80: 100) to give 742 mg (81%) of the title compound as a foam.

【0091】IRスペクトル (film)cm-1 :3250,1760,17
00,1625 NMR スペクトル(270MHz,CDCl3)δppm:0.12(9H,s),1.03
(3H,t,J=7Hz),1.23(3H,d,J=6Hz),1.25(3H,t,J=7Hz),1.2
2-1.31(3H,m),2.95-3.12(4H,m),3.25-3.85(2H,m),3.90
(1H,dd,J=2Hz,4Hz),4.14(1H,quint,J=6Hz),6.07-6.18(1
H,brs),7.32-7.35(1H,m),7.41-7.61(3H,m) マススペクトル(m/z):450(M+,C22H34N2O4SSi) 参考例2 (1R,5S,6S)−2−〔(2S,4
S)−3−ジメチルカルバモイル−1−(4−ニトロベ
ンジルオキシカルボニル)−4−ピロリジニルチオ〕−
1−メチル−6−〔(R)−1−トリメチルシリルオキ
シエチル〕−1−カルバペン−2−エム−3−カルボン
酸4−ニトロベンジルエステル
IR spectrum (film) cm −1 : 3250,1760,17
00,1625 NMR spectrum (270MHz, CDCl 3 ) δppm: 0.12 (9H, s), 1.03
(3H, t, J = 7Hz), 1.23 (3H, d, J = 6Hz), 1.25 (3H, t, J = 7Hz), 1.2
2-1.31 (3H, m), 2.95-3.12 (4H, m), 3.25-3.85 (2H, m), 3.90
(1H, dd, J = 2Hz, 4Hz), 4.14 (1H, quint, J = 6Hz), 6.07-6.18 (1
H, brs), 7.32-7.35 (1H, m), 7.41-7.61 (3H, m) Mass spectrum (m / z): 450 (M + , C 22 H 34 N 2 O 4 SSi) Reference example 2 (1R , 5S, 6S) -2-[(2S, 4
S) -3-Dimethylcarbamoyl-1- (4-nitrobenzyloxycarbonyl) -4-pyrrolidinylthio]-
1-Methyl-6-[(R) -1-trimethylsilyloxyethyl] -1-carbapene-2-em-3-carboxylic acid 4-nitrobenzyl ester

【0092】[0092]

【化21】 [Chemical 21]

【0093】(2S,4S)−2−ジメチルカルバモイ
ル−1−(4−ニトロベンジルオキシカルボニル)−4
−メルカプトピロリジン68mg(0.19mmol)
のテトラヒドロフラン2ml溶液を氷浴で冷却し1Mブ
ロモマグネシウムイソプロピルシクロヘキシルアミドテ
トラヒドロフラン溶液0.19ml(0.19mmo
l)を2分間で滴下した。同温度でさらに10分間撹拌
し、実施例5の化合物のテトラヒドロフラン溶液1ml
を加えた。同温度で15分撹拌した後、氷水を加え反応
液を酢酸エチルで希釈し、塩化アンモニウム水溶液、飽
和食塩水で順次洗浄した。溶媒を留去して得られた残渣
をシリカゲル10gを用いるカラムクロマトグラフィー
に付し、酢酸エチルで溶出して、泡状物質として標記化
合物94mg(78%)を得た。
(2S, 4S) -2-Dimethylcarbamoyl-1- (4-nitrobenzyloxycarbonyl) -4
-Mercaptopyrrolidine 68 mg (0.19 mmol)
2 ml of tetrahydrofuran solution of is cooled in an ice bath and 0.19 ml of 1M bromomagnesium isopropyl cyclohexyl amide tetrahydrofuran solution (0.19 mmo
1) was added dropwise in 2 minutes. The mixture was stirred at the same temperature for 10 minutes, and 1 ml of a tetrahydrofuran solution of the compound of Example 5 was added.
Was added. After stirring at the same temperature for 15 minutes, ice water was added and the reaction solution was diluted with ethyl acetate and washed successively with an aqueous ammonium chloride solution and saturated saline. The solvent was evaporated and the obtained residue was subjected to column chromatography using 10 g of silica gel and eluted with ethyl acetate to give 94 mg (78%) of the title compound as a foamy substance.

【0094】IRスペクトル (film)cm-1 :1773,1711,16
55,1522,1345,1142,845 NMR スペクトル(270MHz,CDCl3)δppm:0.13(4.5H,s),1.1
4(4.5H,s,),1.25-1.29(6H,m),1.89-2.00(1H,m),2.67-2.
80(1H,m),2.94(1.5H,s),2.98(1.5H,s),3.00(1.5H,s),3.
11(1.5H,s),3.22-3.27(1H,m),3.30-3.40(1H,m),3.46-3.
57(1H,m),3.60-3.76(1H,m),4.02-4.30(3H,m),4.72(0.5
H,t,J=8Hz),4.76(0.5H,t,J=8Hz),5.07(0.5H,d,J=14Hz),
5.22(1H,s),5.25(1H,d,J=14Hz),5.30(0.5H,d,J=14Hz),
5.46(1H,d,J=14Hz),7.44(1H,d,J=9Hz),7.52(1H,d,J=9H
z),7.65(2H,d,J=9Hz),8.20(1H,d,9Hz),8.21(3H,d,J=9H
z) マススペクトル(m/z):754(M+(C35H43N5O11SSi)-CH3) 参考例3 (1R,5S,6S)−2−〔(2S,4
S)−2−ジメチルカルバモイル−1−(4−ニトロベ
ンジルオキシカルボニル)−4−ピロリジニルチオ〕−
1−メチル−6−〔(R)−1−t−ブチルジメチルシ
リルオキシエチル〕−1−カルバペン−2−エム−3−
カルボン酸4−ニトロベンジルエステル
IR spectrum (film) cm −1 : 1773,1711,16
55,1522,1345,1142,845 NMR spectrum (270MHz, CDCl 3 ) δppm: 0.13 (4.5H, s), 1.1
4 (4.5H, s,), 1.25-1.29 (6H, m), 1.89-2.00 (1H, m), 2.67-2.
80 (1H, m), 2.94 (1.5H, s), 2.98 (1.5H, s), 3.00 (1.5H, s), 3.
11 (1.5H, s), 3.22-3.27 (1H, m), 3.30-3.40 (1H, m), 3.46-3.
57 (1H, m), 3.60-3.76 (1H, m), 4.02-4.30 (3H, m), 4.72 (0.5
H, t, J = 8Hz), 4.76 (0.5H, t, J = 8Hz), 5.07 (0.5H, d, J = 14Hz),
5.22 (1H, s), 5.25 (1H, d, J = 14Hz), 5.30 (0.5H, d, J = 14Hz),
5.46 (1H, d, J = 14Hz), 7.44 (1H, d, J = 9Hz), 7.52 (1H, d, J = 9H
z), 7.65 (2H, d, J = 9Hz), 8.20 (1H, d, 9Hz), 8.21 (3H, d, J = 9H
z) Mass spectrum (m / z): 754 ( M + (C 35 H 43 N 5 O 11 SSi) -CH 3) Reference Example 3 (1R, 5S, 6S) -2 - [(2S, 4
S) -2-Dimethylcarbamoyl-1- (4-nitrobenzyloxycarbonyl) -4-pyrrolidinylthio]-
1-Methyl-6-[(R) -1-t-butyldimethylsilyloxyethyl] -1-carbapene-2-em-3-
Carboxylic acid 4-nitrobenzyl ester

【0095】[0095]

【化22】 [Chemical formula 22]

【0096】a)参考例2と同様の条件で、実施例6の
化合物を用い標記化合物を86%の収率で泡状物質とし
て得た。
A) Using the compound of Example 6 under the same conditions as in Reference Example 2, the title compound was obtained as a foamy substance in a yield of 86%.

【0097】b)参考例2と同様の条件で、実施例8の
化合物を用い標記化合物を83%の収率で泡状物質とし
て得た。
B) Using the compound of Example 8 under the same conditions as in Reference Example 2, the title compound was obtained as a foamy substance in a yield of 83%.

【0098】c)実施例9の化合物50mg(0.07
1mmol),(2S,4S)−ジメチルカルバモイル
−1−(4−ニトロベンジルオキシカルボニル)−4−
メルカプトピロリジン53mg(0.086mmo
l)、臭化マグネシウムエーテル錯体76mg(0.2
94mmol)のテトラヒドロフラン懸濁液にジイソプ
ロピルエチルアミン25μl(0.144mmol)を
加え94時間撹拌した。反応液を酢酸エチルで希釈し、
水、飽和食塩水で洗浄した後溶媒を留去した。残渣をシ
リカゲルカラムクロマトグラフィーで精製し、標記化合
物53mg(69%)を得た。 IRスペクトル (film)cm-1 :1775,1713,1657,1522,134
5,1142,837 NMR スペクトル(270MHz,CDCl3)δppm:0.07-0.09(6H,m),
0.85(4.5H,s),0.87(4.5H,s),1.23-1.29(6H,m),1.88-2.0
0(1H,m),2.67-2.81(1H,m),2.94(1.5H,s),2.98(1.5H,s),
2.99(1.5H,s)3.11(1.5H,s),3.23-3.41(2H,m),3.46-3.57
(1H,m),3.61-3.78(1H,m),4.03-4.32(3H,m),4.73(0.5H,
t,J=8Hz),4.77(0.5H,t,J=8Hz),5.07(0.5H,d,J=13Hz),5.
22(1H,s),5.25(1H,d,J=13Hz),5.30(0.5H,d,J=13Hz),5.4
5(1H,d,J=13Hz),7.45(1H,d,9Hz),7.52(1H,d,J=9Hz),7.6
5(2H,d,J=9Hz),8.20(1H,d,9Hz),8.21(3H,d,J=9Hz) マススペクトル(m/z):754(M+(C38H49N5O11SSi)-C4H9) 参考例4 (1R,5S,6S)−2−〔(2S,4
S)−2−ジメチルカルバモイル−1−(4−ニトロベ
ンジルオキシカルボニル)−4−ピロリジニルチオ〕−
1−メチル−6−〔(R)−1−ヒドロキシエチル〕−
1−カルバペン−2−エム−3−カルボン酸4−ニトロ
ベンジルエステル
C) Compound of Example 9 (50 mg, 0.07)
1 mmol), (2S, 4S) -Dimethylcarbamoyl-1- (4-nitrobenzyloxycarbonyl) -4-
53 mg of mercaptopyrrolidine (0.086 mmo
l), magnesium bromide ether complex 76 mg (0.2
25 μl (0.144 mmol) of diisopropylethylamine was added to a tetrahydrofuran suspension of 94 mmol) and the mixture was stirred for 94 hours. Dilute the reaction solution with ethyl acetate,
After washing with water and saturated saline, the solvent was distilled off. The residue was purified by silica gel column chromatography to give the title compound 53 mg (69%). IR spectrum (film) cm -1 : 1775,1713,1657,1522,134
5,1142,837 NMR spectrum (270MHz, CDCl 3) δppm: 0.07-0.09 (6H, m),
0.85 (4.5H, s), 0.87 (4.5H, s), 1.23-1.29 (6H, m), 1.88-2.0
0 (1H, m), 2.67-2.81 (1H, m), 2.94 (1.5H, s), 2.98 (1.5H, s),
2.99 (1.5H, s) 3.11 (1.5H, s), 3.23-3.41 (2H, m), 3.46-3.57
(1H, m), 3.61-3.78 (1H, m), 4.03-4.32 (3H, m), 4.73 (0.5H,
t, J = 8Hz), 4.77 (0.5H, t, J = 8Hz), 5.07 (0.5H, d, J = 13Hz), 5.
22 (1H, s), 5.25 (1H, d, J = 13Hz), 5.30 (0.5H, d, J = 13Hz), 5.4
5 (1H, d, J = 13Hz), 7.45 (1H, d, 9Hz), 7.52 (1H, d, J = 9Hz), 7.6
5 (2H, d, J = 9Hz), 8.20 (1H, d, 9Hz), 8.21 (3H, d, J = 9Hz) Mass spectrum (m / z): 754 (M + (C 38 H 49 N 5 O 11 SSi) -C 4 H 9 ) Reference Example 4 (1R, 5S, 6S) -2-[(2S, 4
S) -2-Dimethylcarbamoyl-1- (4-nitrobenzyloxycarbonyl) -4-pyrrolidinylthio]-
1-methyl-6-[(R) -1-hydroxyethyl]-
1-carbapene-2-em-3-carboxylic acid 4-nitrobenzyl ester

【0099】[0099]

【化23】 [Chemical formula 23]

【0100】a)(i)実施例4の化合物467mg
(0.843mmol)、80%m−クロロ過安息香酸
201mg(0.932mmol)を用い、実施例7の
反応、処理で粗製s−オキシド464mgを得た。これ
をクロマト精製することなく次の反応に用いた。
A) (i) 467 mg of the compound of Example 4
(0.843 mmol) and 80% m-chloroperbenzoic acid (201 mg, 0.932 mmol) were used to carry out the reaction and treatment of Example 7 to obtain 464 mg of crude s-oxide. This was used for the next reaction without chromatographic purification.

【0101】(ii)(2S,4S)−ジメチルカルバモ
イル−1−(4−ニトロベンジルオキシカルボニル)−
4−メルカプトピロリジン347mg(0.982mm
ol)のテトラヒドロフラン3ml溶液を氷冷し、1M
ブロモマグネシウムイソプロピルシクロヘキシルアミド
テトラヒドロフラン溶液0.97ml(0.97mmo
l)を4分間で滴下して、さらに10分間撹拌した。こ
の溶液に(i)で得られた粗製s−オキシド464mg
のテトラヒドロフラン2ml溶液を加え、さらに30分
間撹拌した。飽和塩化アンモニウム水溶液を加え、水を
加えた後、酢酸エチルで3回抽出した。有機層を合わ
せ、水飽和食塩水で順次洗浄し、濃縮した油状の残渣を
シリカゲル50gを用いるカラムクロマトグラフィーに
付しメタノール−酢酸エチル(1:9)で溶出し標記の
化合物365mg(62%)を泡状物質として得た。
(Ii) (2S, 4S) -Dimethylcarbamoyl-1- (4-nitrobenzyloxycarbonyl)-
4-Mercaptopyrrolidine 347 mg (0.982 mm
ol) in 3 ml of tetrahydrofuran and ice-cooled
Bromomagnesium isopropyl cyclohexyl amide tetrahydrofuran solution 0.97 ml (0.97 mmo
l) was added dropwise over 4 minutes and stirred for a further 10 minutes. 464 mg of crude s-oxide obtained in (i) was added to this solution.
2 ml of tetrahydrofuran solution of was added, and the mixture was further stirred for 30 minutes. A saturated aqueous ammonium chloride solution was added, water was added, and the mixture was extracted 3 times with ethyl acetate. The organic layers were combined, washed successively with saturated brine and the concentrated oily residue was subjected to column chromatography using 50 g of silica gel and eluted with methanol-ethyl acetate (1: 9) to give 365 mg (62%) of the title compound. Was obtained as a foam.

【0102】b)参考例2の化合物55mg(0.07
1mmol)のメタノール2ml溶液にクエン酸−水和
物8mg(0.039mmol)を加え、室温下35分
間撹拌した。溶媒を留去して得られる残渣をシリカゲル
5gを用いるカラムクロマトグラフィーに付し、メタノ
ール−酢酸エチル=1:9で溶出し標記の化合物42m
g(84%)をガラス状物質として得た。
B) 55 mg (0.07) of the compound of Reference Example 2
To a solution of 1 mmol) in 2 ml of methanol was added citric acid hydrate 8 mg (0.039 mmol), and the mixture was stirred at room temperature for 35 minutes. The solvent was evaporated and the obtained residue was subjected to column chromatography using 5 g of silica gel and eluted with methanol-ethyl acetate = 1: 9 to give 42 m of the title compound.
g (84%) was obtained as a glass.

【0103】IRスペクトル (film)cm-1 :3500-3300,17
71,1707,1649,1522,1345,1140,855 NMR スペクトル(270MHz,CDCl3)δppm:1.25(1.5H,d,J=7H
z),1.28(1.5H,d,J=7Hz),1.34(3H,d,J=6Hz),1.86-1.99(1
H,m),2.40-3.20(1H,broad),2.67-2.81(1H,m),2.94(1.5
H,s),2.99(3H,s),3.11(1.5H,s),3.23-3.29(1H,m),3.34-
3.76(3H,m),4.04-4.29(3H,m),4.73(0.5H,t,J=8Hz),4.78
(0.5H,t,J=8Hz),5.07(0.5H,d,J=14Hz),5.21(1H,s),5.22
(0.5H,d,J=14Hz),5.23(1H,d,J=14Hz),5.48(1H,d,J=14H
z),7.43(1H,d,J=8Hz),7.51(1H,d,J=8Hz),7.64(2H,d,J=8
Hz),8.20(1H,d,J=9Hz),8.17-8.22(3H,m) 参考例5 (R)−2−[(3S,4S)−3−
[(R)−1−(t−ブチルジメチルシリルオキシ)エ
チル]−2−オキソ−4−アゼチジニル]チオプロピオ
ン酸 S−2−ジエチルカルバモイルフェニルエステル
IR spectrum (film) cm −1 : 3500-3300,17
71,1707,1649,1522,1345,1140,855 NMR spectrum (270MHz, CDCl 3 ) δppm: 1.25 (1.5H, d, J = 7H
z), 1.28 (1.5H, d, J = 7Hz), 1.34 (3H, d, J = 6Hz), 1.86-1.99 (1
H, m), 2.40-3.20 (1H, broad), 2.67-2.81 (1H, m), 2.94 (1.5
H, s), 2.99 (3H, s), 3.11 (1.5H, s), 3.23-3.29 (1H, m), 3.34-
3.76 (3H, m), 4.04-4.29 (3H, m), 4.73 (0.5H, t, J = 8Hz), 4.78
(0.5H, t, J = 8Hz), 5.07 (0.5H, d, J = 14Hz), 5.21 (1H, s), 5.22
(0.5H, d, J = 14Hz), 5.23 (1H, d, J = 14Hz), 5.48 (1H, d, J = 14H
z), 7.43 (1H, d, J = 8Hz), 7.51 (1H, d, J = 8Hz), 7.64 (2H, d, J = 8
Hz), 8.20 (1H, d, J = 9Hz), 8.17-8.22 (3H, m) Reference Example 5 (R) -2-[(3S, 4S) -3-
[(R) -1- (t-Butyldimethylsilyloxy) ethyl] -2-oxo-4-azetidinyl] thiopropionic acid S-2-diethylcarbamoylphenyl ester

【0104】[0104]

【化24】 [Chemical formula 24]

【0105】1)特開平4−174099号公報の参考
例12に記載されているチオプロピオン酸 S−(2−
ジエチルカルバモイル)フェニルエステル3.20g
(12.1mmol)とt−ブチルジメチルクロロシラ
ン3.64g(24.1mmol)のN,N−ジメチル
ホルムアミド12mlとテトラヒドロフラン12mlの
溶液にトリエチルアミン1.7ml(12.2mmo
l)を加え室温で3分間攪拌した。この溶液を−78℃
に冷却し、リチウムビス(トリメチルシリル)アミド
1.0Mテトラヒドロフラン溶液12.1mlを20分
間で滴下した。同温度で30分間攪拌した後、飽和重リ
ウ水約10mlを加え反応を終結させた。反応液をヘキ
サンで抽出し、有機層をとり順次水で2回、2N Na
OHで1回、水で3回、さらに飽和食塩水で1回洗浄し
た。硫酸マグネシウムで溶液を乾燥した後、溶媒を留去
し残渣を再度ヘキサンに溶解させた。クロマト用アルミ
ナ9.0gを加え15分間攪拌した後、アルミナをろ去
しアルミナをヘキサンで洗った。ろ液と洗液を合わせ溶
媒を留去し、Z(O)−1−t−ブチルジメチルシリル
オキシ−1−(2−ジエチルカルバモイル)フェニルチ
オ−1−プロペン4.24gを得た。NMRスペクトル
(270MHz)より、Z(O)及びE(O)−異性体
の比は20以上であった。
1) Thiopropionic acid S- (2-, described in Reference Example 12 of JP-A-4-174099.
Diethylcarbamoyl) phenyl ester 3.20 g
1.7 ml of triethylamine (12.2 mmol) was added to a solution of 12 ml of N, N-dimethylformamide (12. 1 mmol) and 3.64 g (24.1 mmol) of t-butyldimethylchlorosilane and 12 ml of tetrahydrofuran.
1) was added and the mixture was stirred at room temperature for 3 minutes. This solution is -78 ° C
After cooling, 12.1 ml of a 1.0 M solution of lithium bis (trimethylsilyl) amide in tetrahydrofuran was added dropwise over 20 minutes. After stirring at the same temperature for 30 minutes, about 10 ml of saturated heavy hydrogen water was added to terminate the reaction. The reaction solution was extracted with hexane, and the organic layer was collected and sequentially washed twice with water, 2N Na
It was washed once with OH, three times with water, and once with saturated saline. After drying the solution with magnesium sulfate, the solvent was distilled off and the residue was dissolved again in hexane. After adding 9.0 g of chromatographic alumina and stirring for 15 minutes, the alumina was filtered off and the alumina was washed with hexane. The filtrate and washings were combined and the solvent was distilled off to obtain 4.24 g of Z (O) -1-t-butyldimethylsilyloxy-1- (2-diethylcarbamoyl) phenylthio-1-propene. From the NMR spectrum (270 MHz), the ratio of Z (O) and E (O) -isomers was 20 or more.

【0106】2)1で得られた化合物4.24gと(3
R,4R)−3−[(R)−1−(t−ブチルジメチル
シリルオキシ)エチル]−4−アセトキシ−2−アゼチ
ジノン1.57g(5.47mmol)の塩化メチレン
55ml溶液に、無水塩化亜鉛1.49g(10.9m
mol)を加え40分間加熱還流した。反応液を室温に
戻し減圧濃縮した。残渣を酢酸エチルに溶解し、水で3
回、飽和食塩水で1回洗浄した。乾燥後溶媒を留去し残
渣にジイソプロピルエーテル約10mlを加えて結晶を
析出させ、標記化合物2.08g(収率77%)を得
た。mp130.5〜132℃ NMR スペクトル(270MHz,CDCl3)δppm:0.08(6H,s),0.87
(9H,s),1.03(4H,t,J=7Hz),1.21(3H,d,J=6Hz),1.25(3H,
t,J=7Hz),1.29(3H,d,J=7Hz),2.96-3.15(4H,m),3.20-3.8
5(2H,broad),3.96(1H,dd,J=2,4Hz),4.19(H,quintet,J=6
Hz),5.90-6.10(1H,br.s),7.30-7.35(1H,m),7.41-7.51(3
H,m) マススペクトル (m/z):492(M,C2540
SSi)
2) 4.24 g of the compound obtained in 1 and (3
R, 4R) -3-[(R) -1- (t-butyldimethylsilyloxy) ethyl] -4-acetoxy-2-azetidinone (1.57 g, 5.47 mmol) in 55 ml of methylene chloride was added to anhydrous zinc chloride. 1.49g (10.9m
(mol) was added and the mixture was heated under reflux for 40 minutes. The reaction solution was returned to room temperature and concentrated under reduced pressure. Dissolve the residue in ethyl acetate and add 3 to water.
And washed once with saturated saline. After drying, the solvent was distilled off, and about 10 ml of diisopropyl ether was added to the residue to precipitate crystals to obtain 2.08 g (yield 77%) of the title compound. mp 130.5-132 ° C NMR spectrum (270 MHz, CDCl 3 ) δppm: 0.08 (6H, s), 0.87
(9H, s), 1.03 (4H, t, J = 7Hz), 1.21 (3H, d, J = 6Hz), 1.25 (3H,
t, J = 7Hz), 1.29 (3H, d, J = 7Hz), 2.96-3.15 (4H, m), 3.20-3.8
5 (2H, broad), 3.96 (1H, dd, J = 2,4Hz), 4.19 (H, quintet, J = 6
Hz), 5.90-6.10 (1H, br.s), 7.30-7.35 (1H, m), 7.41-7.51 (3
H, m) mass spectrum (m / z): 492 (M + , C 25 H 40 N
2 O 4 SSi)

Claims (3)

【特許請求の範囲】[Claims] 【請求項1】 一般式 【化1】 [式中、R1 は水素原子または水酸基の保護基を示し、 R2 は炭素数1乃至6個の直鎖若しくは分枝鎖のアルキ
ル基、炭素数1乃至6個の直鎖若しくは分枝鎖のアルコ
キシ基、ハロゲン原子、フェニル基又はフェノキシ基を
示し、R3 は−CYNR56 基(式中、Yは酸素又は
硫黄原子を示し、R5 及びR6 はそれぞれ独立に炭素数
1乃至6個の直鎖若しくは分枝鎖のアルキル基又はフェ
ニル基を示すか、R5 とR6 が一緒になって式−(CH2)
m (X)L(CH2)n−基(式中、m及びnは同一又は異って0
乃至5(但し、m+nは2以上である。)を示し、Lは
0または1、Xは酸素原子を示す。)を示し、 R3'は水素原子、炭素数1乃至6個の直鎖若しくは分枝
鎖のアルキル基、炭素数1乃至6個の直鎖若しくは分枝
鎖のアルコキシ基、水酸基、ハロゲン原子、シアノ基、
ニトロ基、アミノ基を示し、 R4 は水素原子またはカルボキシ基の保護基を示し、 kは0,1,又は2を示す]を有する1β−カルバペネ
ム誘導体。
1. A general formula: [Wherein R 1 represents a hydrogen atom or a hydroxyl-protecting group, R 2 represents a straight-chain or branched-chain alkyl group having 1 to 6 carbon atoms, a straight-chain or branched chain having 1 to 6 carbon atoms] An alkoxy group, a halogen atom, a phenyl group or a phenoxy group, R 3 is a —CYNR 5 R 6 group (in the formula, Y represents an oxygen atom or a sulfur atom, and R 5 and R 6 each independently have a carbon number of 1 to 1). 6 straight chain or branched chain alkyl groups or phenyl groups are shown, or R 5 and R 6 are taken together to form the formula-(CH 2 ).
m (X) L (CH 2 ) n -group (wherein m and n are the same or different and are 0
To 5 (provided that m + n is 2 or more), L represents 0 or 1, and X represents an oxygen atom. R 3 ′ represents a hydrogen atom, a linear or branched alkyl group having 1 to 6 carbon atoms, a linear or branched alkoxy group having 1 to 6 carbon atoms, a hydroxyl group, a halogen atom, Cyano group,
A nitro group or an amino group, R 4 represents a hydrogen atom or a protecting group for a carboxy group, and k represents 0, 1, or 2].
【請求項2】 一般式 【化2】 [式中、R1 は水素原子または水酸基の保護基(トリ置
換シリル基、アラルキルオキシカルボニル基またはハロ
ゲンもしくはアルコキシで置換されていてもよいアセチ
ル基を示す)を示し、R2 は炭素数1乃至3個の直鎖若
しくは分枝鎖のアルキル基、炭素数1乃至2個の直鎖若
しくは分枝鎖のアルコキシ基、ハロゲン原子、フェニル
基又はフェノキシ基を示し、R3 は−CYNR56
(式中、Yは酸素原子を示し、R5 及びR6 はそれぞれ
独立に炭素数1乃至3個の直鎖若しくは分枝鎖のアルキ
ル基又はフェニル基を示すか、R5 とR6 が一緒になっ
て式−(CH2)m (X)L(CH2)n−基(式中、m及びnは同一
又は異って0乃至5(但し、m+nは2以上である。)
を示し、Lは0または1、Xは酸素原子を示す。)を示
し、R3'は水素原子、炭素数1乃至3個の直鎖若しくは
分枝鎖のアルキル基、炭素数1乃至2個の直鎖若しくは
分枝鎖のアルコキシ基、ハロゲン原子またはニトロ基を
示し、R4 は水素原子またはカルボキシ基の保護基(ハ
ロゲンで置換されていてもよい炭素数1乃至4個の直鎖
若しくは分枝鎖のアルキル基、アラルキル基、ハロゲン
で置換されていてもよい炭素数2乃至4個の直鎖若しく
は分枝鎖のアルケニル基または2−(トリメチルシリ
ル)エチル基を示す)を示し、kは0,1,又は2を示
す]を有する1β−カルバペネム誘導体。
2. A general formula: [In the formula, R 1 represents a hydrogen atom or a hydroxyl-protecting group (a tri-substituted silyl group, an aralkyloxycarbonyl group or an acetyl group which may be substituted with halogen or alkoxy), and R 2 has 1 to 1 carbon atoms. 3 linear or branched alkyl groups, 1 or 2 linear or branched alkoxy groups having 1 to 2 carbon atoms, a halogen atom, a phenyl group or a phenoxy group, wherein R 3 is a -CYNR 5 R 6 group (In the formula, Y represents an oxygen atom, R 5 and R 6 each independently represent a linear or branched alkyl group having 1 to 3 carbon atoms or a phenyl group, or R 5 and R 6 are the same. turned by the formula - (CH 2) m (X ) L (CH 2) n - group (wherein, m and n are 0 to 5 I same or different (provided that, m + n is 2 or more).
, L is 0 or 1, and X is an oxygen atom. R 3 ′ represents a hydrogen atom, a linear or branched alkyl group having 1 to 3 carbon atoms, a linear or branched alkoxy group having 1 to 2 carbon atoms, a halogen atom or a nitro group. R 4 represents a hydrogen atom or a protecting group for a carboxy group (which may be substituted with a halogen, and may be substituted with a linear or branched alkyl group having 1 to 4 carbon atoms, an aralkyl group, or a halogen). A preferable straight chain or branched alkenyl group having 2 to 4 carbon atoms or a 2- (trimethylsilyl) ethyl group) and k is 0, 1, or 2].
【請求項3】 一般式 【化3】 [式中、R1 は水素原子または水酸基の保護基(トリ置
換シリル基、アラルキルオキシカルボニル基またはハロ
ゲンもしくはアルコキシで置換されていてもよいアセチ
ル基を示す)を示し、R2 はメチル基を示し、R3 は−
CYNR56 基(式中、Yは酸素原子を示し、R5
びR6 はそれぞれ独立に炭素数1乃至3個の直鎖若しく
は分枝鎖のアルキル基又はフェニル基を示すか、R5
6 が一緒になって式−(CH2)m (X)L(CH2)n−基(式
中、m及びnは同一又は異って0乃至5(但し、m+n
は2以上である。)を示し、Lは0または1、Xは酸素
原子を示す。)を示し、R3'は水素原子、炭素数1乃至
3個の直鎖若しくは分枝鎖のアルキル基、炭素数1乃至
2個の直鎖若しくは分枝鎖のアルコキシ基、ハロゲン原
子またはニトロ基を示し、R4 は水素原子またはカルボ
キシ基の保護基(ハロゲンで置換されていてもよい炭素
数1乃至4個の直鎖若しくは分枝鎖のアルキル基、アラ
ルキル基、ハロゲンで置換されていてもよい炭素数2乃
至4個の直鎖若しくは分枝鎖のアルケニル基または2−
(トリメチルシリル)エチル基を示す)を示し、kは
0,1,又は2を示す]を有する1β−カルバペネム誘
導体。
3. A general formula: [In the formula, R 1 represents a hydrogen atom or a protective group of a hydroxyl group (indicates a tri-substituted silyl group, an aralkyloxycarbonyl group, or an acetyl group which may be substituted with halogen or alkoxy), and R 2 represents a methyl group. , R 3 is −
CYNR 5 R 6 group (in the formula, Y represents an oxygen atom, R 5 and R 6 each independently represent a linear or branched alkyl group having 1 to 3 carbon atoms or a phenyl group, or R 5 And R 6 together form a-(CH 2 ) m (X) L (CH 2 ) n- group (in the formula, m and n are the same or different and are 0 to 5 (provided that m + n
Is 2 or more. ), L is 0 or 1, and X is an oxygen atom. R 3 ′ represents a hydrogen atom, a linear or branched alkyl group having 1 to 3 carbon atoms, a linear or branched alkoxy group having 1 to 2 carbon atoms, a halogen atom or a nitro group. R 4 represents a hydrogen atom or a protecting group for a carboxy group (which may be substituted with a halogen, and may be substituted with a linear or branched alkyl group having 1 to 4 carbon atoms, an aralkyl group, or a halogen). A straight-chain or branched alkenyl group having 2 to 4 carbon atoms or 2-
(Representing (trimethylsilyl) ethyl group) and k represents 0, 1, or 2].
JP6015043A 1993-02-12 1994-02-09 Synthetic intermediate for 1beta-substituted carbapenem antibiotic substance Pending JPH06293765A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP6015043A JPH06293765A (en) 1993-02-12 1994-02-09 Synthetic intermediate for 1beta-substituted carbapenem antibiotic substance

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2402993 1993-02-12
JP5-24029 1993-02-12
JP6015043A JPH06293765A (en) 1993-02-12 1994-02-09 Synthetic intermediate for 1beta-substituted carbapenem antibiotic substance

Publications (1)

Publication Number Publication Date
JPH06293765A true JPH06293765A (en) 1994-10-21

Family

ID=26351110

Family Applications (1)

Application Number Title Priority Date Filing Date
JP6015043A Pending JPH06293765A (en) 1993-02-12 1994-02-09 Synthetic intermediate for 1beta-substituted carbapenem antibiotic substance

Country Status (1)

Country Link
JP (1) JPH06293765A (en)

Similar Documents

Publication Publication Date Title
FI66001C (en) PROCEDURE FOR THE FRAMSTATION OF 3-AMINOETHYLTIO-6- (1-HYDROXYTHYL) -1-AZABICYCLO (3.2.0) HEPT-2-EN-7-ON-2-CARBOXYLSYRA OCH DESS PHARMACEUTICAL FORM SALT OCH ESTRAR
EP0037080B1 (en) 4-(3-carboxy-2-oxopropyl)-azetidino-2-ones and process for their preparation
EP0188816B1 (en) Novel beta-lactams and their production
US5589592A (en) Process for preparing β-lactam derivative and synthetic intermediate
IE842848L (en) Producing penems
JPS6355514B2 (en)
EP0679652B1 (en) Process for preparing carbapenem compounds
JP4481829B2 (en) Novel synthetic intermediate of carbapenem compound for oral administration and process for producing the same
HU198068B (en) New process for producing penem derivatives
JPH06293765A (en) Synthetic intermediate for 1beta-substituted carbapenem antibiotic substance
JPH06157531A (en) Synthetic intermediate for 1beta-substituted carbapenem antibiotic substance
KR101059339B1 (en) Method for preparing carbapenem compound for oral administration
JPH0318638B2 (en)
JPH0625243A (en) Production of 1-methylcarbapenem derivative
US4769451A (en) Synthesis of carbapenems using n-substituted azetidinones
PL163376B1 (en) Method of obtaining pheneme derivatives
EP0061205B1 (en) 2-penem compounds; a method for their preparation and pharmaceutical compositions comprising them
FI105810B (en) Use of (3S, 4S) -3 - [(1R) -1-trialkylsilyloxyethyl] -4 - [(1R) - (heterocyclyl-thiocarbonyl) ethyl] azetidin-2-one derivative in the preparation of carbapenem antibiotics
JPH0466872B2 (en)
US4895940A (en) Process for the preparation of penems
JP3959128B2 (en) Method for producing carbapenem compounds
JPH0379355B2 (en)
JPH08283267A (en) Carbapenem-based compound and its production
JPWO2003089432A1 (en) Method for producing carbapenem derivatives
KR900004877B1 (en) Process for preparing of 1-carbaphenem -2-m-3-carboxyacid derivatives